- Conditions: Wheezing; Allergy
Interventions: Dietary Supplement: Cholecalciferol; Drug: Cholecalciferol
Sponsors: Case Western Reserve University; Case Western Reserve University; National Heart, Lung, and Blood Institute (NHLBI); NIH Office of Dietary Supplements
Not yet recruiting - verified May 2012 - Conditions: Vitamin D Deficiency; Preterm Infants; Bronchopulmonary Dysplasia
Interventions: Dietary Supplement: Cholecalciferol; Dietary Supplement: Cholecalciferol; Dietary Supplement: Placebo
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; Children's Health System, Alabama
Not yet recruiting - verified May 2012 - Conditions: HIV Infection; Tuberculosis
Interventions: Drug: Lopinavir/Ritonavir; Drug: Lopinavir/Ritonavir; Drug: Raltegravir; Drug: Isoniazid; Drug: Pyridoxine; Drug: Pyrazinamide; Drug: Ethambutol; Drug: Rifabutin; Drug: Rifampin
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Conditions: Hemodialysis Patients; Vitamin D Insufficiency; Vitamin D Deficiency
Interventions: Drug: Omega-3 fatty acid ethylester 90; Other: Olive oil; Other: cholecalciferol
Sponsors: Dong-A University; Dong-A University
Recruiting - verified May 2012 - Conditions: Magnesium Deficiency; Calcium Metabolism Disorders
Intervention: Dietary Supplement: vitamin D3
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; National Institutes of Health (NIH); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Severe Sepsis
Interventions: Drug: Vitamin C; Drug: placebo
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified May 2012 - Conditions: Leukemia; Lymphoma
Interventions: Biological: rituximab; Drug: cyclophosphamide; Drug: cytarabine; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: hydrocortisone sodium succinate; Drug: leucovorin calcium; Drug: methotrexate; Drug: methylprednisolone; Drug: prednisone; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified May 2012 - Condition: Polymorphic Light Eruption
Interventions: Drug: Oral Vitamin D 3; Drug: Miglyol 812 N
Sponsors: Medical University of Graz; Medical University of Graz; FWF, Austrian Science Fund
Recruiting - verified May 2012 - Condition: Shock
Interventions: Drug: Ascorbic Acid; Other: Ringers Lactate or Normal Saline
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey
Not yet recruiting - verified February 2012 - Condition: Severe Thermal Injury, Greater Than 20% TBSA
Interventions: Drug: High Dose Ascorbic Acid; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Not yet recruiting - verified April 2012 - Condition: Gastric Cancer
Interventions: Drug: Onartuzumab; Drug: Placebo; Drug: mFOLFOX6
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified May 2012 - Conditions: Malnutrition; Diarrhea; Child Development
Interventions: Behavioral: Water quality; Behavioral: Sanitation; Behavioral: Handwashing; Behavioral: Water quality, Sanitation, Handwashing (Combined WASH); Behavioral: Nutrition; Behavioral: Nutrition, Water quality, Sanitation, Handwashing
Sponsors: International Centre for Diarrhoeal Disease Research, Bangladesh; International Centre for Diarrhoeal Disease Research, Bangladesh
Not yet recruiting - verified April 2012 - Conditions: Diabetic Nephropathy; Persistent Proteinuria With Type II Diabetes
Interventions: Procedure: Percutaneous renal denervation and TMNS; Drug: Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified March 2012 - Condition: Pulmonary Tuberculosis
Interventions: Drug: Active Sodium Phenylbutyrate and active cholecalciferol; Drug: Placebo Sodium Phenylbutyrate plus active cholecalciferol; Drug: Active Sodium Phenylbutyrate and placebo cholecalciferol; Drug: Placebo Sodium Phenylbutyrate plus placebo cholecalciferol
Sponsors: International Centre for Diarrhoeal Disease Research, Bangladesh; International Centre for Diarrhoeal Disease Research, Bangladesh; Dept. of medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; National Tuberculosis Reference Laboratory, National Institute of Diseases of Chest and Hospital (NIDCH), Dhaka, Bangladesh; Biology Institute, University of Iceland, Sturlugata 7, 101 Reykjavik
Recruiting - verified April 2012 - Condition: Metastatic Pancreas Cancer
Interventions: Drug: 5FU, leucovorin, oxaliplatin; Drug: Gemcitabine
Sponsors: Alberta Health Services; Alberta Health Services
Not yet recruiting - verified April 2012 - Condition: Vitamin A Deficiency
Interventions: Dietary Supplement: retinyl palmitate; Dietary Supplement: Placebo
Sponsors: USDA, Western Human Nutrition Research Center; USDA, Western Human Nutrition Research Center; International Centre for Diarrhoeal Disease Research, Bangladesh; World Health Organization
Recruiting - verified April 2012 - Condition: Atrial Fibrillation
Interventions: Drug: Ascorbic Acid; Other: Identical Placebo
Sponsors: Regional Hospital of Scranton; Regional Hospital of Scranton
Not yet recruiting - verified April 2012 - Condition: Peyronie's Disease
Interventions: Drug: Vitamin D2; Drug: Vitamin E; Drug: Testosterone Pellets
Sponsors: Men's Health Boston; Men's Health Boston
Recruiting - verified April 2012 - Condition: Scar
Intervention:
Sponsors: Ohio State University; Chandan K Sen; Carotech Inc.
Recruiting - verified April 2012 - Condition: Cardio-vascular Diseases
Intervention: Other: therapeutic education program
Sponsors: University Hospital, Montpellier; University Hospital, Montpellier
Not yet recruiting - verified April 2012 - Conditions: Hypercholesterolemia, Familial; Heterozygous Familial Hypercholesterolemia
Interventions: Drug: MK-0524A; Drug: MK-0524A
Sponsors: Merck; Merck
Not yet recruiting - verified April 2012 - Condition: Vitamin B12 Deficiency
Interventions: Dietary Supplement: L-5-methyltetrahydrofolate (Metafolin ®); Dietary Supplement: folic acid; Dietary Supplement: Placebo
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified April 2012 - Conditions: Vitamin D Deficiency; Hepatocellular Carcinoma
Interventions: Drug: Vitamin D3 4000 IU; Drug: Vitamin D3 2000 IU
Sponsors: Mount Sinai School of Medicine; Andrea Branch
Recruiting - verified April 2012 - Conditions: Liver Cancer; Pancreatic Cancer
Interventions: Drug: FOLFOX7 (Folinic acid, 5-Fluorouracil, and Oxaliplatin); Device: TheraSpheres
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Nordion (Canada) Inc.
Recruiting - verified April 2012 - Conditions: Alopecia; Breast Cancer
Intervention: Drug: compound 31543 Calcitriol
Sponsors: Berg Pharma,LLC; Berg Pharma,LLC
Not yet recruiting - verified April 2012 - Conditions: Ovarian Cancer; Endometrial Cancer
Interventions: Biological: E39 peptide vaccine; Other: Clinical tracking for disease progression/recurrence
Sponsors: San Antonio Military Medical Center; COL George Peoples, MD, FACS
Recruiting - verified April 2012 - Conditions: Ischemic Stroke; Transient Ischemic Attack (TIA)
Intervention: Other: Vitamin E tocotrienol (TCT) pills ; Low dose Aspirin
Sponsors: Ohio State University; Chandan K Sen; Government of Malaysia
Recruiting - verified April 2012 - Condition: Vitamin D Deficiency
Intervention: Dietary Supplement: Cholecalciferol
Sponsors: Georgia Health Sciences University; Georgia Health Sciences University
Recruiting - verified April 2012 - Condition: Down Syndrome
Intervention: Drug: thyroid hormone and folinic acid
Sponsors: Institut Jerome Lejeune; Institut Jerome Lejeune; Ascopharm Groupe Novasco; Effi-stat; Medi.Axe; LC2; BIOMNIS
Recruiting - verified April 2012 - Condition: Vitamin D Deficiency
Interventions: Other: completion of a questionnaire; Other: Blood draw
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Not yet recruiting - verified March 2012 - Conditions: Chemical Injuries; Unspecified Complication of Corneal Transplant; Autoimmune Diseases; Ocular Cicatricial Pemphigoid; Stevens Johnson Syndrome; Lupus Erythematosus, Systemic; Rheumatoid Arthritis; Other Autoimmune Diseases
Intervention: Drug: Riboflavin
Sponsors: Massachusetts Eye and Ear Infirmary; Massachusetts Eye and Ear Infirmary
Recruiting - verified April 2012 - Condition: Focus of the Study: DNA Damage Due to Medical Diagnostic X-ray
Interventions: Radiation: Low-dose radiation exposure; Radiation: High-dose radiation exposure; Other: No radiation exposure
Sponsors: University of Zurich; University of Zurich
Recruiting - verified April 2012 - Condition: Myopathic Symptoms
Interventions: Drug: Ergocalciferol; Drug: Placebo
Sponsors: Cedars-Sinai Medical Center; Cedars-Sinai Medical Center
Recruiting - verified March 2012 - Condition: Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: University of Zurich; University of Zurich
Not yet recruiting - verified March 2012 - Condition: Polycystic Ovary Syndrome
Interventions: Drug: Placebo; Drug: Inositol
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Recruiting - verified April 2012 - A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural MesotheliomaConditions: Malignant; Pleural; Mesothelioma
Interventions: Biological: TroVax®; Drug: Pemetrexed; Drug: Cisplatin; Dietary Supplement: Vitamin B12; Dietary Supplement: Folic Acid; Drug: Dexamethasone
Sponsors: Wales Cancer Trials Unit; Wales Cancer Trials Unit; Velindre NHS Trust; June Hancock Mesothelioma Research Fund; Velindre Cancer Centre Stepping Stones Appeal
Not yet recruiting - verified March 2012 - Condition: Facioscapulohumeral Muscular Dystrophy
Interventions: Procedure: Taking of blood; Dietary Supplement: needle biopsy of the vastus lateralis muscle; Dietary Supplement: Vit C Vit E Zn Se; Dietary Supplement: Placebo Vit E Placebo Vit C Zn Se
Sponsors: University Hospital, Montpellier; University Hospital, Montpellier; Hospital Clinical Research Project 2010; Association Amis FSH France; FSH Dutch Fondation The Netherland
Recruiting - verified May 2012 - Condition: Cholangiocarcinoma
Intervention: Drug: Oxaliplatin, Fluorouracil, Leucovorin, Capecitabine
Sponsors: Peking University; Peking University
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention:
Sponsors: University of Aarhus; University of Aarhus; Aarhus University Hospital
Recruiting - verified April 2012 - Condition: Mild Cognitive Impairment
Intervention:
Sponsors: Pamlab, L.L.C.; Pamlab, L.L.C.; Clionsky Neuro Systems, Inc.
Recruiting - verified May 2012 - Condition: Healthy Subjects
Intervention: Dietary Supplement: Gamma-Delta Tocotrienol and Tocotrienol Rich Fraction
Sponsors: Malaysia Palm Oil Board; Malaysia Palm Oil Board; University of Malaya
Not yet recruiting - verified April 2012 - Condition: Ulcerative Colitis
Interventions: Drug: Propionyl-L-Carnitine; Drug: Placebo
Sponsors: sigma-tau i.f.r. S.p.A.; sigma-tau i.f.r. S.p.A.; PRA International
Not yet recruiting - verified April 2012 - Condition: Psoriasis
Interventions: Drug: STF 115469 Foam; Drug: Vehicle Foam
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified May 2012 - Conditions: Chronic Kidney Disease Stage 1; Chronic Kidney Disease Stage 2
Interventions: Drug: Calcitriol; Drug: placebo
Sponsors: Taixing People's Hospital; Taixing People's Hospital
Not yet recruiting - verified March 2012 - Condition: Contrast Media Induced Nephropathy
Intervention: Drug: Acetylcysteine, Phosphodiesterase type 5 inhibitor ,Carnitine
Sponsors: The Nazareth Hospital, Israel; The Nazareth Hospital; Western Galilee Hospital-Nahariya
Not yet recruiting - verified March 2012 - Condition: Deficiency of Vitamin D3
Interventions: Dietary Supplement: D3 2000 IU/day; Dietary Supplement: D3 4000 IU/day; Dietary Supplement: vitamin D3 weekly; Dietary Supplement: vitamin D3 800 IU/day
Sponsors: Jewish Home, San Francisco; Jewish Home, San Francisco; University of California, San Francisco
Not yet recruiting - verified March 2012 - Conditions: Osteoarthritis; Traumatic Arthritis; Total Knee Joint Prosthesis
Intervention: Device: 3DKnee™ System with Vitamin E UHMWPE Tibial Inserts
Sponsors: Encore Medical, L.P.; Encore Medical, L.P.; DJO Incorporated
Recruiting - verified May 2012 - Conditions: Osteoporosis; Postmenopausal Osteoporosis
Interventions: Drug: Odanacatib; Drug: Alendronate; Other: Placebo (odanacatib); Dietary Supplement: Cholecalciferol (Vitamin D3); Dietary Supplement: Calcium carbonate; Other: Placebo (alendronate)
Sponsors: Merck; Merck
Not yet recruiting - verified April 2012 - Condition: Red Blood Cell Folate
Interventions: Dietary Supplement: Folic acid; Dietary Supplement: L-5-MTHF; Other: Placebo
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Folic Acid; Drug: Placebo
Sponsors: Postgraduate Institute of Medical Education and Research; Postgraduate Institute of Medical Education and Research
Recruiting - verified April 2012 - Condition: Scleroderma
Intervention: Other: Blood sample
Sponsors: Meir Medical Center; Meir Medical Center
Not yet recruiting - verified January 2012 - Conditions: Polycystic Ovary Syndrome; Hirsutism; Menstrual Irregularity
Interventions: Drug: myo-inositol 1500 gr; Drug: myo-inositol 2000 gr + folic acid 200 mcg
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Recruiting - verified March 2012 - Condition: Pelvic Organ Prolapse
Intervention: Other: Blood draw for the study participants
Sponsors: TriHealth Inc.; TriHealth Inc.
Recruiting - verified March 2012 - Condition: Psoriasis
Intervention: Drug: calcipotriene
Sponsors: GlaxoSmithKline; Stiefel, a GSK Company; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Ventricular Thrombosis Mural Following Myocardial Infarction
Intervention: Drug: Absence of Acenocoumarol
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); VU University of Amsterdam; Erasmus Medical Center
Recruiting - verified March 2012 - Conditions: Respiratory Tract Infection; Vitamin D Deficiency
Interventions: Dietary Supplement: Cholecalciferol; Dietary Supplement: Placebo
Sponsors: Menzies Research Institute Tasmania; Menzies Research Institute Tasmania; Royal Hobart Hospital Research Foundation (funding source)
Recruiting - verified April 2012 - Conditions: Stunting; Wasting
Interventions: Dietary Supplement: Wheat Soy Blend (WSB++); Dietary Supplement: Chickpea based complementary food supplement; Dietary Supplement: Rice based complementary food supplement; Dietary Supplement: Plumpy Doz
Sponsors: Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research, Bangladesh; United Nations World Food Programme (WFP); DSM Ltd
Not yet recruiting - verified March 2012 - Condition: Metabolic Syndrome
Intervention: Dietary Supplement: vitamin D3 (cholecalciferol)
Sponsors: Allina Health System; Allina Health System
Recruiting - verified March 2012 - Condition: Postpoliomyelitis Syndrome
Interventions: Drug: L-carnitine and piracetam; Drug: Placebo
Sponsors: Biolab Sanus Farmaceutica; Biolab Sanus Farmaceutica
Not yet recruiting - verified March 2012 - Condition: Diabetes Mellitus, Type 2
Intervention: Other: Cycling
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Not yet recruiting - verified March 2012 - Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Test group; Drug: Reference group
Sponsors: DreamPharma; DreamPharma
Recruiting - verified April 2012 - Condition: -kRAS Mutant Stage IV Colorectal Cancer
Intervention: Drug: Vitamin C
Sponsors: Thomas Jefferson University; Thomas Jefferson University
Recruiting - verified March 2012 - Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
Sponsors: Thomas Jefferson University; Thomas Jefferson University
Recruiting - verified March 2012 - Condition: Neurodegenerative Disorders
Intervention: Drug: nicotinamide
Sponsors: Imperial College London; Imperial College London
Not yet recruiting - verified April 2012 - Condition: Acute Kidney Injury
Intervention: Drug: vitamin E +Selenium
Sponsors: Tehran University of Medical Sciences; Tehran University of Medical Sciences
Recruiting - verified March 2012 - Condition: Sarcopenia
Interventions: Other: Exercise Intervention; Dietary Supplement: Supplement Intervention
Sponsors: Tufts University; Tufts University; Uppsala University; Karolinska Institutet
Recruiting - verified February 2012 - Condition: Vitamin D Deficiency
Interventions: Dietary Supplement: Vitamin D3; Dietary Supplement: Vitamin D3
Sponsors: Tufts University; Tufts University; Office of Dietary Supplements (ODS); National Heart, Lung, and Blood Institute (NHLBI); Boston University; Children's Hospital Boston
Recruiting - verified February 2012 - Conditions: Autism; Vitamin D Deficiency
Intervention: Drug: Liquid Vitamin D
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified February 2012 - Condition: Primary Prevention of Prostate Cancer
Interventions: Dietary Supplement: Quercetin supplement; Dietary Supplement: Genistein supplement; Dietary Supplement: Placebo
Sponsors: University of Hohenheim; University of Hohenheim; Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany; University Hospital Tübingen, Department of Urology, Tübingen; Provision of study products: Quercegen Pharmaceuticals LLC
Recruiting - verified May 2012 - Condition: Ulcerative Colitis
Interventions: Drug: Propionyl-L-Carnitine; Drug: Placebo
Sponsors: sigma-tau i.f.r. S.p.A.; sigma-tau i.f.r. S.p.A.
Not yet recruiting - verified February 2012 - Conditions: Obese; Disorder of Vitamin C; Growth Hormone Secretion Abnormality
Interventions: Dietary Supplement: Placebo; Dietary Supplement: Vitamin C 250 mg once daily; Dietary Supplement: Vitamin C 1,000 mg once daily
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Not yet recruiting - verified March 2012 - Condition: Anemia of Chronic Kidney Disease
Intervention: Drug: Cholecalciferol
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified February 2012 - Condition: Immune Tolerance
Intervention: Drug: Cholecalciferol
Sponsors: Medical University of Graz; Medical University of Graz
Recruiting - verified February 2012 - Condition: Endstage Kidney Disease
Interventions: Drug: Vitamin K1; Drug: Placebo simple syrup
Sponsors: Clinical Evaluation Research Unit at Kingston General Hospital; Dr. Rachel Holden; Kingston General Hospital
Not yet recruiting - verified February 2012 - Condition: Psoriasis Vulgaris
Interventions: Drug: LEO 90100; Drug: Betamethasone plus calcipotriol; Drug: Ointment vehicle; Drug: LEO 90100 vehicle
Sponsors: LEO Pharma; LEO Pharma
Not yet recruiting - verified February 2012 - Condition: Thrombosis
Intervention: Dietary Supplement: Vitamin K2
Sponsors: Danisco; Danisco
Recruiting - verified February 2012 - Conditions: Carcinoma; Liver Diseases; Hepatocellular Carcinoma
Intervention: Drug: S-1 combined with Leucovorin
Sponsors: Second Military Medical University; Second Military Medical University
Recruiting - verified February 2012 - Condition: Metastatic Colorectal Cancer
Intervention: Drug: fluorouracil/irinotecan/levo-folinic acid/bevacizumab
Sponsors: University of Rome Tor Vergata; University of Rome Tor Vergata
Not yet recruiting - verified February 2012 - Conditions: Heart Failure; Acidosis, Lactic; Thiamine Deficiency
Interventions: Drug: Vitamin B1-ratiopharm; Drug: Placebo
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified February 2012 - Condition: HIV+
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: University Hospitals of Cleveland; University Hospitals of Cleveland; Emory University
Recruiting - verified January 2012 - Condition: Metastatic Breast Cancer
Interventions: Drug: Lapatinib + 1,23 mg Eribulin; Drug: Lapatinib + 1,76 mg Eribulin
Sponsors: German Breast Group; German Breast Group
Recruiting - verified February 2012 - Condition: Colorectal Cancer
Interventions: Drug: Endostatins (Endostar); Drug: Oxaliplatin; Drug: Leucovorin; Drug: 5-fluorouracil
Sponsors: Chinese Academy of Medical Sciences; Chinese Academy of Medical Sciences; Simcere Pharmaceutical Co., Ltd
Recruiting - verified February 2012 - Condition: Angelman Syndrome
Intervention: Drug: minocycline
Sponsors: University of South Florida; University of South Florida
Recruiting - verified February 2012 - Condition: Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)
Intervention: Drug: Arm B : mFolfirinox
Sponsors: UNICANCER; UNICANCER
Recruiting - verified February 2012 - Condition: Muscle Power
Interventions: Dietary Supplement: Vitamin D; Dietary Supplement: Placebo
Sponsors: Oklahoma State University; Oklahoma State University; Mid America Athletic Trainers Association
Recruiting - verified January 2012 - Condition: Colorectal Cancer Metastatic
Interventions: Drug: Cetuximab; Drug: 5-fluorouracil; Drug: leucovorin
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC
Not yet recruiting - verified January 2012 - Condition: Osteoporosis
Interventions: Drug: AK156; Drug: Placebo
Sponsors: Asahi Kasei Pharma Corporation; Asahi Kasei Pharma Corporation
Recruiting - verified January 2012 - Conditions: Pancreatic Neoplasms; Pancreatic Cancer
Intervention: Drug: Gemcitabine with escalating ascorbic acid
Sponsors: University of Iowa; University of Iowa; Susan L Bader Foundation of Hope; The Holden Comprehensive Cancer Center; The National Cancer Institute (NCI)
Not yet recruiting - verified May 2012 - Condition: Metastatic Colorectal Cancer
Interventions: Drug: FOLFOX + bevacizumab; Dietary Supplement: Vitamin D; Dietary Supplement: Vitamin D
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute
Recruiting - verified April 2012 - Condition: Oligospermia
Intervention: Dietary Supplement: Vitamale
Sponsors: Hillel Yaffe Medical Center; Hillel Yaffe Medical Center
Not yet recruiting - verified January 2012 - Condition: Vitamin D Deficiency
Interventions: Dietary Supplement: cholecalciferol; Dietary Supplement: cholecalciferol; Dietary Supplement: cholecalciferol; Dietary Supplement: cholecalciferol
Sponsors: Tufts University; Tufts University; Pfizer
Recruiting - verified May 2012 - Conditions: Crohn's Disease; Fatigue
Interventions: Dietary Supplement: L-carnitine; Other: Placebo
Sponsors: University of California, San Francisco; University of California, San Francisco
Not yet recruiting - verified January 2012 - Condition: Colorectal Cancer
Interventions: Drug: capecitabine; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)
Not yet recruiting - verified January 2012 - Conditions: Chronic Heart Failure; Vitamin D Adverse Reaction
Intervention: Drug: Vigantol oil and MCT oil
Sponsors: Semmelweis University; Semmelweis University
Recruiting - verified February 2012 - Condition: Brain Metastasis
Interventions: Drug: Trental; Dietary Supplement: Vitamin E
Sponsors: University of Cincinnati; University of Cincinnati
Recruiting - verified January 2012 - Condition: Chronic Lymphoid Leukemia
Interventions: Drug: Cholecalciferol; Drug: oleum neutralicum
Sponsors: Semmelweis University; Semmelweis University
Recruiting - verified February 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Recruiting - verified January 2012 - Condition: Vitamin D Deficiency
Interventions: Dietary Supplement: Cholecalciferol; Dietary Supplement: Cholecalciferol
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia
Recruiting - verified May 2012 - Condition: Solid Tumors
Interventions: Drug: tivantinib; Drug: omeprazole; Drug: s-warfarin; Drug: caffeine; Dietary Supplement: vitamin K; Drug: digoxin; Drug: midazolam
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.; Medpace, Inc.
Recruiting - verified January 2012 - Condition: Ovarian Cancer
Intervention: Drug: EC-17
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified January 2012 - Condition: Proteinuria
Interventions: Drug: Calcitriol; Drug: Placebo
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Recruiting - verified April 2012 - Conditions: Colorectal Cancer Metastatic; Liver Metastases; KRAS Wild Type Colorectal Cancer
Intervention: Drug: 5-FU, Folinic Acid, Oxaliplatin, Bevacizumab, Panitumumab
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC; Amgen; Roche Pharma AG
Not yet recruiting - verified January 2012 - Condition: Progressive Supranuclear Palsy
Intervention: Drug: alpha-lipoic acid and L-acetyl carnitine
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified February 2012 - Conditions: Gastric Adenocarcinoma With Peritoneal Carcinomatosis; Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis; Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis
Interventions: Drug: catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel; Drug: Fluorouracil, leucovorin, oxaliplatin, docetaxel
Sponsors: AIO-Studien-gGmbH; AIO-Studien-gGmbH; Fresenius Biotech GmbH
Recruiting - verified January 2012 - Condition: Myocardial Stunning
Interventions: Drug: levosimendan; Drug: Vitamin B 12
Sponsors: Tampere University Hospital; Tampere University Hospital
Recruiting - verified April 2012 - Condition: Cutaneous Lupus Erythematosus
Intervention: Dietary Supplement: vitamin D
Sponsors: Emory University; Emory University; Dermatology Foundation
Recruiting - verified January 2012 - Condition: Drug Safety
Interventions: Drug: Colistin; Drug: Colistin + Ascorbic acid
Sponsors: Mahidol University; Mahidol University; Siriraj Hospital
Not yet recruiting - verified December 2011 - Conditions: Diabetes Mellitus, Type 2; Glucose Intolerance; Vitamin D Deficiency
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: Karolinska Institutet; Karolinska Institutet
Not yet recruiting - verified December 2011 - Conditions: Stage 5 Chronic Kidney Diseases; Moderate to Severe Secondary Hyperparathyroidism
Intervention: Drug: Paricalcitol
Sponsors: Abbott; Abbott
Not yet recruiting - verified April 2012 - Condition: Advanced Gastric Cancer
Interventions: Drug: Pazopanib; Drug: 5-FU, Oxaliplatin, Leukovorin (FLO)
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany
Recruiting - verified January 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer; Gastric Cancer
Interventions: Drug: FOLFOX regimen; Drug: docetaxel; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Muscle Pain; Joint Pain
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: Park Nicollet Institute; Park Nicollet Institute; University of Minnesota - Clinical and Translational Science Institute; University of Southern California
Recruiting - verified December 2011 - Condition: Glioma
Intervention: Drug: 5-Aminolevulinic acid (ALA) or ascorbic acid (placebo)
Sponsors: St. Joseph's Hospital and Medical Center, Phoenix; St. Joseph's Hospital and Medical Center, Phoenix
Recruiting - verified January 2012 - Condition: Anaemia
Interventions: Drug: Iron, Folic acid and Cyanocobalamin; Drug: Iron and Folic Acid
Sponsors: Indian Council of Medical Research; Indian Council of Medical Research; Lady Irwin College, University of Delhi
Recruiting - verified January 2012 - Conditions: Vitamin D Deficiency; Metabolic Syndrome; Prediabetes
Interventions: Dietary Supplement: Mushroom fortified with 600 IU of vitamin D2; Dietary Supplement: Mushroom fortified with 4000 IU of vitamin D2; Dietary Supplement: Commercially available Vitamin D3 (600 IU) supplement; Dietary Supplement: Commercially available Vitamin D3 (4000 IU) supplement
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine
Recruiting - verified December 2011 - Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Vitamin D3
Sponsors: Johns Hopkins University; Johns Hopkins University; Virginia Mason Hospital/Medical Center; Oregon Health and Science University; University of California, San Francisco; Washington University School of Medicine; Mount Sinai School of Medicine; University of Pennsylvania
Recruiting - verified April 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: Taipei Veterans General Hospital,Taiwan; Taipei Veterans General Hospital,Taiwan
Recruiting - verified December 2011 - Condition: Urothelial Carcinoma
Interventions: Drug: Pemetrexed; Drug: Cisplatin; Drug: Dexamethasone; Drug: Vitamins
Sponsors: Asan Medical Center; Asan Medical Center; Korea Association for Clinical Oncology
Recruiting - verified December 2011 - Conditions: Fallopian Tube Cancer; Fatigue; Neuropathy; Neurotoxicity; Ovarian Cancer; Pain; Primary Peritoneal Cavity Cancer
Interventions: Dietary Supplement: acetyl-L-carnitine hydrochloride; Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel; Other: placebo
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified April 2012 - Condition: Metastatic Pancreatic Cancer
Interventions: Drug: MM-398; Drug: 5 Fluorouracil; Drug: Leucovorin
Sponsors: Merrimack Pharmaceuticals; Merrimack Pharmaceuticals
Recruiting - verified May 2012 - Condition: Biliary Tract Cancer
Interventions: Drug: Fluorouracil; Drug: Leucovorin; Drug: Oxaliplatin; Drug: Irinotecan
Sponsors: Soon Chun Hyang University; Soon Chun Hyang University
Recruiting - verified December 2011 - Condition: Peripheral Arterial Disease
Interventions: Drug: Placebo; Drug: Cholecalciferol
Sponsors: University Hospital, Basel, Switzerland; University Hospital, Basel, Switzerland
Recruiting - verified March 2012 - Condition: Inflammation
Intervention: Device: SUPRA-HFR
Sponsors: ASL Cagliari; ASL Cagliari; Bellco s.r.l.; Istituto Superiore di Sanità
Recruiting - verified December 2011 - Condition: HMG COA Reductase Inhibitor Adverse Reaction
Interventions: Drug: Vitamin D; Drug: Placebo
Sponsors: Centre hospitalier universitaire de Québec; Centre hospitalier universitaire de Québec; Canadian Institutes of Health Research (CIHR); Laval University
Not yet recruiting - verified December 2011 - Conditions: Vitamin D Deficiency; Cardiovascular Diseases
Intervention: Dietary Supplement: Vitamin D3
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified December 2011 - Condition: Metastatic Pancreatic Cancer
Intervention: Drug: Veliparib and 5-FU and Oxaliplatin and Leucovorin
Sponsors: Georgetown University; Georgetown University; Abbott
Recruiting - verified December 2011 - Condition: Adrenomyeloneuropathy
Interventions: Drug: N-acetylcysteine; Drug: lipoic acid; Drug: vitamin E
Sponsors: Onofre, Aurora Pujol, M.D.; Onofre, Aurora Pujol, M.D.; Ministerio de Sanidad, Politica Social e Igualdad; Fundacion Hesperia
Recruiting - verified May 2012 - Conditions: Osteoporosis; Bone Diseases, Metabolic
Intervention: Behavioral: Bone Mineral Density Result Letter and Bone Health Brochure
Sponsors: University of Iowa; University of Iowa; University of Alabama at Birmingham; Kaiser Permanente; University of Pittsburgh
Recruiting - verified March 2012 - Condition: Breast Cancer
Interventions: Drug: calcium and cholecalciferol; Drug: calcium and cholecalciferol
Sponsors: Centre Val d'Aurelle - Paul Lamarque; Centre Val d'Aurelle - Paul Lamarque
Recruiting - verified November 2011 - Condition: Pancreatic Cancer
Intervention: Drug: LDE225; Fluorouracil; Leucovorin; Oxaliplatin; Irinotecan
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Dana-Farber Cancer Institute
Recruiting - verified December 2011 - Condition: Cognitive Performance
Intervention: Dietary Supplement: food bar
Sponsors: Institut de Recherche pour le Developpement; Institut de Recherche pour le Developpement; Can Tho University, Can Tho, Viet Nam; National Institute of Nutrition, Ministry of Health, Vietnam; GAIN, Geneva, Switzerland; ILSI, Japan
Not yet recruiting - verified December 2011 - Condition: Melanoma, Skin
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: Stanford University; Stanford University; National Institutes of Health (NIH)
Not yet recruiting - verified November 2011 - Conditions: Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-Cell Lymphoma
Interventions: Drug: Alisertib; Drug: Pralatrexate; Drug: Romidepsin; Drug: Gemcitabine
Sponsors: Millennium Pharmaceuticals, Inc.; Millennium Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Condition: Vitamin B 12 Deficiency
Interventions: Drug: oral Cobalamin (vitamin B12); Drug: intramuscular Cobalamin (vitamin B12)
Sponsors: Gerencia de Atención Primaria, Madrid; Gerencia de Atención Primaria, Madrid
Not yet recruiting - verified November 2011 - Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione; Drug: none-control group
Sponsors: James A. Haley Veterans Administration Hospital; James A. Haley Veterans Administration Hospital
Recruiting - verified December 2011 - Conditions: Heart Failure; Vitamin D Deficiency
Interventions: Drug: CHOLECALCIFEROL; Drug: PLACEBO
Sponsors: Azienda Unita' Sanitaria Locale Di Modena; Azienda Unita' Sanitaria Locale Di Modena; Abiogen Pharma
Recruiting - verified November 2011 - Condition: Breast Cancer
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: Stanford University; Robert Carlson
Recruiting - verified December 2011 - Condition: Hypertension
Interventions: Dietary Supplement: Vitamin D (cholecalciferol); Drug: Tekturna(Aliskiren) plus placebo
Sponsors: Wayne State University; Wayne State University; Novartis
Recruiting - verified November 2011 - Condition: Vitamin A Deficiency
Intervention: Dietary Supplement: Vitamin A (retinyl palmitate).
Sponsors: London School of Hygiene and Tropical Medicine; London School of Hygiene and Tropical Medicine; World Health Organization
Recruiting - verified April 2012 - Condition: Secondary Hyperparathyroidism
Intervention: Drug: Cinacalcet HCl
Sponsors: Istituto Giannina Gaslini; ENRICO VERRINA
Recruiting - verified November 2011 - Condition: Premature Infants
Interventions: Dietary Supplement: cholecalciferal; Dietary Supplement: cholecalciferol
Sponsors: University of Nebraska; University of Nebraska
Not yet recruiting - verified November 2011 - Condition: Bariatric Surgery Candidate
Interventions: Dietary Supplement: AquaVanta Chewable Tablet; Dietary Supplement: Flinstones Complete; Dietary Supplement: Nature Made Calcium Softgels; Dietary Supplement: Nature Made Calcium Softgels; Dietary Supplement: Twin Labs Iron Caps; Dietary Supplement: Rexall Vitamin B12 Tablet
Sponsors: Yasoo Health; Yasoo Health
Recruiting - verified November 2011 - Condition: Gestational Diabetes
Interventions: Dietary Supplement: inositol + folic acid; Dietary Supplement: inositol + folic acid; Drug: Folic Acid
Sponsors: AGUNCO Obstetrics and Gynecology Centre; AGUNCO Obstetrics and Gynecology Centre
Recruiting - verified January 2012 - Condition: Pancreatic Cancer
Interventions: Biological: ganitumab; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: oxaliplatin; Other: placebo; Other: questionnaire administration
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Not yet recruiting - verified March 2012 - Condition: Diffuse Large B Cell Lymphoma
Interventions: Drug: Ofatumumab; Drug: Etoposide; Drug: Ifosfamid; Drug: Mesna; Drug: Cytarabine; Drug: Methotrexate; Drug: Leukovorin; Drug: G-CSF
Sponsors: Polish Lymphoma Research Group; Polish Lymphoma Research Group
Not yet recruiting - verified November 2011 - Conditions: Hypertensive Disease; Deficiency of Vitamin D3
Interventions: Dietary Supplement: Vitamin D3; Dietary Supplement: Placebo
Sponsors: Martin-Luther-Universität Halle-Wittenberg; Martin-Luther-Universität Halle-Wittenberg; German Federal Ministry of Education and Research
Not yet recruiting - verified December 2011 - Conditions: Vitamin D Deficiency; Obesity; Type 2 Diabetes Mellitus
Intervention: Dietary Supplement: Vitamin D3
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; University of Washington
Recruiting - verified May 2012 - Conditions: Short Segment Barrett's Esophagus; Long Segment Barrett's Esophagus
Interventions: Drug: Omeprazole; Drug: Vitamin D3; Drug: Vitamin D3; Procedure: upper endoscopy
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center
Recruiting - verified May 2012 - Condition: Chronic Fatigue Syndrome
Interventions: Drug: Nutraceutical supplements; Drug: Placebo
Sponsors: Columbia University; Columbia University
Not yet recruiting - verified November 2011 - Condition: Colorectal Cancer
Interventions: Drug: Axitinib; Drug: Bevacizumab; Drug: 5-FU; Drug: 5-FU; Drug: Leucovorin; Drug: Oxaliplatin
Sponsors: Sarah Cannon Research Institute; Sarah Cannon Research Institute; Pfizer
Recruiting - verified January 2012 - Condition: Optic Neuritis
Interventions: Drug: Vitamin D; Drug: Vitamin D withheld
Sponsors: Isfahan University of Medical Sciences; Isfahan University of Medical Sciences
Recruiting - verified November 2011 - Conditions: Glioblastoma; GBM; Glioma; High Grade Glioma
Intervention: Drug: Trans Sodium Crocetinate (TSC)
Sponsors: Diffusion Pharmaceuticals LLC; Diffusion Pharmaceuticals LLC
Recruiting - verified April 2012 - Condition: Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma
Intervention: Drug: oxaliplatin
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified November 2011 - Condition: Vitamin D Deficiency
Interventions: Dietary Supplement: cholecalciferol; Dietary Supplement: Placebo
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; Merck
Not yet recruiting - verified November 2011 - Condition: Chronic Atrophic Gastritis (CAG)
Interventions: Drug: Gastropylor Complex Capsules; Other: Placebo Comparator
Sponsors: Xinjiang Biochemical Pharmaceutical Co., Ltd.; Xinjiang Biochemical Pharmaceutical Co., Ltd.
Recruiting - verified November 2011 - Condition: Dry Eye Syndrome
Intervention: Dietary Supplement: Omega 3, Vitamins A, D3 and E
Sponsors: Eye and Vision Technologies and Research Institute; Eye and Vision Technologies and Research Institute; ZeaVision, Inc.
Recruiting - verified March 2012 - Condition: Vitamin D Deficiency
Interventions: Dietary Supplement: cholecalciferol; Dietary Supplement: ergocalciferol; Dietary Supplement: Placebo
Sponsors: Martin-Luther-Universität Halle-Wittenberg; Ulrike Lehmann
Not yet recruiting - verified December 2011 - Conditions: Keratoconus; Corneal Ectasia
Interventions: Drug: Riboflavin; Drug: Riboflavin
Sponsors: Cornea and Laser Eye Institute; Cornea and Laser Eye Institute
Recruiting - verified November 2011 - Conditions: Cirrhosis; Acanthocytosis
Intervention: Dietary Supplement: Vitamin E supplement (tocofersolan)
Sponsors: University Hospital, Geneva; University Hospital, Geneva
Recruiting - verified November 2011 - Condition: Neurotoxicity
Intervention: Drug: Vitamin D3
Sponsors: West Virginia University; Gerald Higa, PharmD.
Recruiting - verified December 2011 - Condition: Hypobetalipoproteinemias
Interventions: Drug: Tocofersolan; Drug: tocopherol alpha
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified October 2011 - Condition: Healthy
Intervention:
Sponsors: West China Hospital; West China Hospital
Not yet recruiting - verified October 2011 - Condition: Acute Respiratory Failure
Intervention: Drug: Thiamine
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; American Medical Association
Recruiting - verified October 2011 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach
Interventions: Drug: 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT), trastuzumab; Drug: Post-operative treatment trastuzumab mono therapy
Sponsors: AIO-Studien-gGmbH; AIO-Studien-gGmbH; Roche Pharma AG
Recruiting - verified January 2012 - Conditions: Cardiovascular Diseases; Cancer
Interventions: Dietary Supplement: Vitamin D3; Dietary Supplement: Vitamin D3; Dietary Supplement: Placebo
Sponsors: University of Eastern Finland; University of Eastern Finland; Academy of Finland; Juho Vainio Foundation; Finnish Foundation for Cardiovascular Research
Not yet recruiting - verified October 2011 - Condition: Chronic Renal Failure
Intervention: Drug: 25-OH-D vitamin
Sponsors: Consorzio Mario Negri Sud; Consorzio Mario Negri Sud
Not yet recruiting - verified October 2011 - Condition: Pancreatic Cancer
Intervention: Drug: Vitamin E δ-Tocotrienol
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI); BioGene Life Science
Recruiting - verified March 2012 - Condition: Bacterial Vaginosis
Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol); Dietary Supplement: Placebo
Sponsors: Ohio State University; Ohio State University
Recruiting - verified October 2011 - Conditions: Alcoholism; Alcohol Amnestic Disorder
Interventions: Behavioral: Neuropsychological testing; Biological: blood draw; Genetic: genetic testing; Other: Brain imaging examination
Sponsors: University Hospital, Caen; University Hospital, Caen; Institut National de la Santé Et de la Recherche Médicale, France; Agence Nationale de la Recherche
Recruiting - verified March 2012 - Condition: Asthma
Intervention: Drug: Vitamin D
Sponsors: Georgia Health Sciences University; Georgia Health Sciences University
Recruiting - verified October 2011 - Conditions: Healthy, no Evidence of Disease; Non-melanomatous Skin Cancer
Interventions: Dietary Supplement: cholecalciferol; Genetic: gene expression analysis; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); University of Arizona; National Cancer Institute (NCI)
Recruiting - verified December 2011 - Condition: Pancreatic Cancer
Intervention: Drug: Vitamin E δ-Tocotrienol
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI); BioGene Life Science
Recruiting - verified March 2012 - Condition: Dyslipidemias
Interventions: Drug: Nicotinic acid; Drug: Placebo
Sponsors: Hospital Universitari de Bellvitge; Xavier Pinto Sala
Not yet recruiting - verified June 2011 - Conditions: Sickle Cell Disease; Vitamin D Deficiency; Acute Chest Syndrome; Asthma; Respiratory Infections
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: Columbia University; Columbia University
Recruiting - verified January 2012 - Conditions: Kidney Failure, Chronic; Disorder of Vitamin D
Interventions: Drug: Hidroferol®; Drug: Paricalcitol: Zemplar®; Drug: Habitual medication
Sponsors: Hospital Universitario de Canarias; Hospital Universitario de Canarias
Recruiting - verified September 2011 - Condition: End Stage Renal Disease
Interventions: Dietary Supplement: B and C renal vitamin plus zinc, selenium and vitamin E; Dietary Supplement: B and C renal vitamin
Sponsors: University of Alberta; Cello Tonelli; Alberta Health Services
Not yet recruiting - verified November 2011 - Conditions: Bladder Cancer; Colorectal Cancer; Endometrial Cancer; Kidney Cancer; Skin Cancer; Uterus Cancer
Intervention: Behavioral: Health and Diet Questionnaire
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Multiple Sclerosis
Interventions: Drug: Verum arm receiving Vitamin D oil; Drug: low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany; NeuroCure
Recruiting - verified February 2012 - Condition: Osteoporosis
Intervention: Drug: MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Chronic Hepatitis C
Intervention: Dietary Supplement: Vit D
Sponsors: Hanyang University; Hanyang University; Roche Pharma AG
Not yet recruiting - verified September 2011 - Condition: HIV-infection/Aids
Interventions: Dietary Supplement: Vitamin D3; Dietary Supplement: Placebo
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia; National Institutes of Health (NIH); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified November 2011 - Conditions: Disorder of Transplanted Kidney; Proteinuria; Albuminuria
Interventions: Drug: Paricalcitol; Drug: Placebo
Sponsors: University Medical Centre Ljubljana; University Medical Centre Ljubljana; Abbott
Not yet recruiting - verified September 2011 - Conditions: Keratoconus; Corneal Ectasia
Interventions: Device: KXL System (15 mW/cm2); Drug: riboflavin ophthalmic solution; Device: KXL System (30 mW/cm2); Device: KXL System (45 mW/cm2)
Sponsors: ACOS; ACOS
Not yet recruiting - verified April 2012 - Condition: Vitamin D Deficiency
Intervention:
Sponsors: Mahidol University; Mahidol University
Recruiting - verified September 2011 - Conditions: Prediabetes; Vitamin D Deficiency
Interventions: Drug: oral cholecalciferol + life style counselling; Drug: placebo + life style counselling
Sponsors: Postgraduate Institute of Medical Education and Research; Postgraduate Institute of Medical Education and Research
Recruiting - verified December 2011 - Condition: Vitamin D Deficiency
Interventions: Drug: Vitamin D3 600,000 units IM; Drug: Vitamin D3 600,000 Orally; Drug: Vitamin D3 200,000 units IM; Drug: Vitamin D3 200,000 Orally
Sponsors: Aga Khan University; Aga Khan University
Recruiting - verified May 2012 - Conditions: Abortion; Blood Loss
Interventions: Drug: Misoprostol; Drug: Folic acid
Sponsors: Boston University; Boston University
Recruiting - verified October 2011 - Condition: Gastrointestinal Tumor
Interventions: Drug: SOM230C LAR; Drug: FOLFIRI Infusion
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Novartis
Recruiting - verified February 2012 - Conditions: Cystic Fibrosis; Respiratory Tract Infections
Intervention: Dietary Supplement: Cholecalciferol
Sponsors: Emory University; Emory University; Cystic Fibrosis Foundation
Not yet recruiting - verified August 2011 - Conditions: Chronic Kidney Disease; Secondary Hyperparathyroidism
Intervention: Drug: Contrast Enhanced Ultrasonography
Sponsors: University of Virginia; University of Virginia
Recruiting - verified January 2012 - Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin; Drug: Folinic Acid; Drug: 5-fluoro-uracil; Drug: Irinotecan; Drug: Bevacizumab; Drug: Cetuximab
Sponsors: UNICANCER; UNICANCER
Recruiting - verified September 2011 - Condition: End Stage Renal Disease
Intervention:
Sponsors: University of Alberta; University of Alberta; Massachusetts General Hospital
Recruiting - verified May 2012 - Condition: HIV-1 Infection
Interventions: Drug: Niacin; Drug: Aspirin; Drug: Fenofibrate
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified October 2011 - Condition: Renal Transplant Candidate for Right Kidney
Interventions: Drug: Cholecalciferol 100 000 UI; Drug: Cholecalciferol 12 000 UI
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Laboratoire Crinex
Recruiting - verified September 2011 - Condition: Coronary Artery Disease
Interventions: Dietary Supplement: Coenzyme Q10; Other: Placebo
Sponsors: Taichung Veterans General Hospital; Taichung Veterans General Hospital
Recruiting - verified August 2011 - Condition: Peripheral T-cell Lymphoma
Interventions: Drug: Pralatrexate Injection; Dietary Supplement: Vitamin B12; Dietary Supplement: Folic Acid
Sponsors: Allos Therapeutics; Allos Therapeutics
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Gulhane Military Medical Academy; Gulhane Military Medical Academy
Recruiting - verified August 2011 - Condition: Vitamin D Deficiency
Interventions: Drug: Vitamin D; Other: Placebo (for Vitamin D)
Sponsors: Meir Medical Center; Meir Medical Center
Not yet recruiting - verified August 2011 - Conditions: Respiratory Tract Infections; Asthma; Avitaminosis
Interventions: Drug: Vitamin D - Cholecalciferol 400 IU; Drug: Vitamin D3 - Cholecalciferol 2000 IU
Sponsors: The Hospital for Sick Children; The Hospital for Sick Children; Mount Sinai Hospital, Canada; St. Michael's Hospital, Toronto
Recruiting - verified September 2011 - Condition: Vitamin D Deficiency
Interventions: Drug: Cholecalciferol; Drug: Cholecalciferol; Drug: Cholecalciferol; Drug: Cholecalciferol
Sponsors: Umeå University; Umeå University
Recruiting - verified November 2011 - Conditions: Infertility; Vitamin D Deficiency
Intervention:
Sponsors: Northwestern University; Northwestern University
Recruiting - verified February 2012 - Condition: Leukemia
Interventions: Drug: Cyclophosphamide; Drug: Mesna; Drug: Doxorubicin; Drug: Vincristine; Drug: Dexamethasone; Drug: Ponatinib; Drug: G-CSF (Filgrastim); Drug: Rituximab; Drug: Methotrexate; Drug: Cytarabine; Drug: Solu-medrol ( Methyl Prednisolone); Drug: Citrovorum (Leucovorin); Drug: Prednisone; Drug: Pegfilgrastim (Neulasta)
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Ariad Pharmaceuticals
Recruiting - verified May 2012 - Condition: Iron Deficiency Anemia
Intervention: Other: Dietary Intervention
Sponsors: PepsiCo Global R&D; PepsiCo Global R&D; PepsiCo - Philippines
Recruiting - verified August 2011 - Condition: Vitamin D Deficiency
Interventions: Dietary Supplement: 400 IU vitamin D3; Dietary Supplement: 2,000 IU Vitamin D3
Sponsors: USDA, Western Human Nutrition Research Center; USDA, Western Human Nutrition Research Center; University of California, Davis
Recruiting - verified April 2012 - Condition: Chronic Obstructive Lung Disease
Interventions: Dietary Supplement: Vitamin D (D3, cholecalciferol); Dietary Supplement: Placebo (cellulose)
Sponsors: Hvidovre University Hospital; Jorgen Vestbo
Recruiting - verified September 2011 - Conditions: Bone Metabolism Biomarkers; Bone Mineral Density; Physical Fitness
Interventions: Drug: Vitamin D3; Behavioral: Home-Based Exercise
Sponsors: University of Rochester; University of Rochester
Not yet recruiting - verified August 2011 - Condition: Burn Injury
Intervention: Dietary Supplement: dl-alpha-tocopheryl acetate
Sponsors: Shriners Hospitals for Children; Shriners Hospitals for Children; University of Texas; Oregon State University
Recruiting - verified March 2012 - Conditions: Chronic Hepatitis; Chronic Hepatitis C; Chronic Alcoholic Hepatitis
Intervention: Drug: High dose vitamin C
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Not yet recruiting - verified August 2011 - Conditions: Sepsis; Septic Shock; Hypotension; Acute Lung Injury
Intervention: Drug: Ascorbic Acid vs. Placebo
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University
Recruiting - verified April 2012 - Conditions: Colorectal Cancer; Cancer of Pancreas; Pancreatic Neoplasm; Malignant Neoplasm of Large Intestine; Malignant Tumor of Colon; Colon Carcinoma; Cancer of Colon; Pancreatic Cancer
Interventions: Drug: FOLFOX6; Biological: EGFRBi armed ATC Infusions
Sponsors: Barbara Ann Karmanos Cancer Institute; Barbara Ann Karmanos Cancer Institute
Recruiting - verified September 2011 - Condition: Type 2 Diabetes
Intervention: Drug: Cholecalciferol
Sponsors: Florida International University; Florida International University
Recruiting - verified August 2011 - Condition: Colorectal Cancer
Interventions: Drug: onartuzumab [MetMAb]; Drug: Placebo; Drug: bevacizumab [Avastin]; Drug: FOLFOX regimen; Drug: leucovorin; Drug: 5-FU
Sponsors: Genentech; Genentech; Sarah Cannon Research Institute
Recruiting - verified January 2012 - Conditions: Malnourished; Stomach Neoplasms; Gastrointestinal Stromal Tumors
Interventions: Dietary Supplement: Ensure powder; Other: Standard care
Sponsors: Seoul National University Hospital; Seoul National University Hospital; Abbott
Recruiting - verified August 2011 - Condition: Colorectal Cancer
Interventions: Biological: bevacizumab; Drug: FOLFIRI regimen; Drug: FOLFIRI-bevacizumab regimen; Drug: FOLFOX regimen; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: oxaliplatin; Other: laboratory biomarker analysis; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Federation Francophone de Cancerologie Digestive
Not yet recruiting - verified October 2011 - Condition: Vitamin D Deficiency
Intervention:
Sponsors: University Hospitals of Cleveland; University Hospitals of Cleveland; Emory-Children's Center
Recruiting - verified February 2012 - Condition: Alzheimer Disease
Interventions: Drug: Memantine; Drug: Vitamin D; Drug: Vitamin D placebo
Sponsors: University Hospital, Angers; University Hospital, Angers
Recruiting - verified March 2011 - Conditions: Malignant Neoplasm of Esophagus; Malignant Neoplasm of Stomach
Interventions: Drug: Oxaliplatin; Drug: Folinic Acid; Drug: 5-fluoro-uracil; Drug: panitumumab; Drug: AMG102
Sponsors: UNICANCER; UNICANCER
Recruiting - verified September 2011 - Conditions: Vitamin D Deficiency; Chronic Pain Syndrome; Inflammatory Response
Intervention: Drug: vitamin D
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified March 2012 - Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin; Drug: Folinic Acid; Drug: 5-fluoro-uracil; Drug: Irinotecan; Drug: Irinotecan; Drug: Bevacizumab; Drug: Cetuximab
Sponsors: UNICANCER; UNICANCER
Recruiting - verified September 2011 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: bendamustine hydrochloride; Drug: cyclophosphamide; Drug: cytarabine; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: leucovorin calcium; Drug: methotrexate; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Maternal and Newborn Health
Intervention: Dietary Supplement: Corn Soya Blend+
Sponsors: University of British Columbia; University of British Columbia; International Relief and Development
Recruiting - verified February 2012 - Conditions: Tuberculosis; HIV Infections
Interventions: Drug: Rifapentine (RPT); Drug: Isoniazid (INH); Dietary Supplement: Pyridoxine (Vitamin B6)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Condition: HIV-1 Infection
Interventions: Drug: Atripla; Drug: Calcium Carbonate; Drug: Vitamin D3; Drug: Placebo for calcium carbonate; Drug: Placebo for vitamin D3
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Conditions: Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Signet Ring Adenocarcinoma of the Colon; Signet Ring Adenocarcinoma of the Rectum; Stage I Colon Cancer; Stage I Rectal Cancer
Interventions: Dietary Supplement: cholecalciferol; Procedure: biopsy; Genetic: protein expression analysis; Other: enzyme-linked immunosorbent assay; Other: laboratory biomarker analysis; Genetic: reverse transcriptase-polymerase chain reaction
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Non-Small Cell Lung Cancer
Intervention:
Sponsors: University of Michigan Cancer Center; University of Michigan Cancer Center
Recruiting - verified August 2011 - Condition: HMG COA Reductase Inhibitor Adverse Reaction
Interventions: Drug: Vitamin D (Cholecalciferol ); Drug: Placebo
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified July 2011 - Conditions: Cognitive/Functional Effects; Leukemia; Neurotoxicity; Pain; Therapy-related Toxicity
Interventions: Drug: clofarabine; Drug: cyclophosphamide; Drug: cytarabine; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: hydrocortisone sodium succinate; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: prednisone; Drug: thioguanine; Drug: vincristine sulfate; Radiation: selective external radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Pancreatic Neoplasms
Interventions: Drug: oxaliplatin; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: fluorouracil; Other: laboratory biomarker analysis; Other: flow cytometry; Other: immunohistochemistry staining method; Other: pharmacological study; Drug: PF-04136309
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Vitamin B-12 Deficiency; Achlorhydria
Intervention: Other: 14C-B12 fortified bread
Sponsors: USDA, Western Human Nutrition Research Center; USDA, Western Human Nutrition Research Center
Recruiting - verified January 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tetrahydrobiopterin (BH4); Drug: non-acetylated salicylate; Dietary Supplement: High Fat Meal; Drug: L-NMMA; Dietary Supplement: Antioxidant Cocktail
Sponsors: Georgia Health Sciences University; Georgia Health Sciences University; American Heart Association
Recruiting - verified July 2011 - Condition: Vitamin D Deficiency
Intervention:
Sponsors: Hospital for Special Surgery, New York; Hospital for Special Surgery, New York
Recruiting - verified July 2011 - Condition: Infection
Intervention: Drug: cholecalciferol
Sponsors: University of Tromso; University of Tromso
Recruiting - verified July 2011 - Conditions: Oxidative Stress; Inflammation; Endothelial Dysfunction
Interventions: Dietary Supplement: Coenzyme Q10; Dietary Supplement: Coenzyme Q10; Dietary Supplement: Placebo
Sponsors: University of Washington; University of Washington; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified February 2012 - Condition: End Stage Renal Disease
Interventions: Dietary Supplement: ergocalciferol supplementation; Other: placebo
Sponsors: Dialysis Clinic, Inc.; Dialysis Clinic, Inc.
Recruiting - verified April 2012 - Condition: Healthy
Interventions: Other: Non-Fortified Control Product; Other: Micronutrient Fortified Test Product
Sponsors: Kraft Foods; Kraft Foods; St. John's Research Institute
Recruiting - verified March 2012 - Conditions: Thyroid; Cancer
Intervention: Drug: alpha-lipoic acids
Sponsors: Asan Medical Center; Asan Medical Center
Recruiting - verified July 2011 - Condition: Pancreatic Cancer
Intervention: Drug: Oxaliplatin, irinotecan, 5-FU & leucovorin
Sponsors: Odense University Hospital; Odense University Hospital
Not yet recruiting - verified June 2011 - Condition: Chronic Stable Angina
Interventions: Drug: Nicorandil; Drug: Atenolol
Sponsors: Ferozsons Laboratories Ltd.; Ferozsons Laboratories Ltd.
Recruiting - verified December 2011 - Condition: Type 2 Diabetes
Interventions: Drug: Paricalcitol; Other: placebo
Sponsors: Mario Negri Institute for Pharmacological Research; Mario Negri Institute for Pharmacological Research; Abbott
Not yet recruiting - verified July 2011 - Conditions: Stable Angina; Coronary Disease
Interventions: Drug: Nicorandil; Drug: basic treatment
Sponsors: Merck KGaA; Merck KGaA; Merck Serono Co., Ltd., China
Recruiting - verified January 2012 - Condition: Pediatric Bipolar Spectrum Disorders
Interventions: Drug: Omega-3; Drug: Inositol
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Condition: Depression
Interventions: Dietary Supplement: Vitamin D3; Dietary Supplement: placebo
Sponsors: Region Syddanmark; Region Syddanmark
Recruiting - verified July 2011 - Condition: Rectal Cancer
Intervention: Other: CCRT
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified September 2011 - Condition: Keratoconus and Ectasia
Interventions: Drug: Riboflavin; Device: VEGA UV-A Illumination System
Sponsors: Topcon Medical Systems, Inc.; Topcon Medical Systems, Inc.
Recruiting - verified July 2011 - Condition: Ectasia
Interventions: Device: VEGA UV-A Illumination System; Drug: Riboflavin
Sponsors: Topcon Medical Systems, Inc.; Topcon Medical Systems, Inc.
Recruiting - verified July 2011 - Condition: Vitamin D Deficiency
Interventions: Dietary Supplement: Vitamin D - Treatment 1; Dietary Supplement: Vitamin D - Treatment 2; Dietary Supplement: Vitamin D - Treatment 3
Sponsors: USDA, Western Human Nutrition Research Center; USDA, Western Human Nutrition Research Center
Recruiting - verified April 2012 - Condition: Asthma
Intervention: Drug: Vitamin D
Sponsors: Hamad Medical Corporation; Hamad Medical Corporation
Recruiting - verified March 2012 - Conditions: Obesity; Vitamin D Deficiency
Intervention: Dietary Supplement: Vitamin D3 and Calcium
Sponsors: The Methodist Hospital System; The Methodist Hospital System; Texas Woman's University
Not yet recruiting - verified July 2011 - Condition: Non Alcoholic Steatohepatitis
Interventions: Drug: pentoxiphylline and Vitamin E; Drug: Vitamin E
Sponsors: Institute of Liver and Biliary Sciences, India; Institute of Liver and Biliary Sciences, India
Recruiting - verified October 2011 - Condition: Vitamin D Deficiency
Intervention:
Sponsors: Medical Corps, Israel Defense Force; Medical Corps, Israel Defense Force
Not yet recruiting - verified June 2011 - Conditions: Arterial Dysfunction; Chronic Kidney Disease
Interventions: Drug: Cholecalciferol; Drug: Calcitriol
Sponsors: University of Colorado, Denver; University of Colorado, Denver; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Condition: Geriatric Bipolar Depression
Intervention: Drug: Coenzyme Q10
Sponsors: Mclean Hospital; Mclean Hospital; National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Conditions: Dermatologic Complications; Malignant Neoplasm; Pain
Interventions: Drug: menadione topical lotion; Other: placebo; Other: questionnaire administration; Procedure: management of therapy complications
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified May 2012 - Condition: Male Infertility
Interventions: Drug: Folic acid; Drug: placebo of folic acid
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified November 2011 - Conditions: Keratoconus; Ectasia
Interventions: Other: Riboflavin Solution; Device: UV-X Illumination System
Sponsors: Columbia University; Columbia University
Available - verified January 2012 - Condition: Colorectal Cancer
Interventions: Biological: bevacizumab; Drug: FOLFIRI-bevacizumab regimen; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: sorafenib tosylate
Sponsors: National Cancer Institute (NCI); Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified October 2011 - Condition: HIV
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: Columbia University; Columbia University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Impaired Fasting Glucose; Impaired Glucose Tolerance
Intervention: Drug: Vitamin D
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Conditions: Vitamin D Deficiency; Insulin Resistance
Intervention: Drug: Vitamin D3 cholecalciferol
Sponsors: University of Leicester; University of Leicester
Not yet recruiting - verified June 2011 - Condition: Vitamin D3
Interventions: Dietary Supplement: Enteral Vitamin D3 50,000 IU; Dietary Supplement: Enteral Vitamin D3 100,000IU; Dietary Supplement: Inactive substance
Sponsors: Emory University; Emory University; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified June 2011 - Conditions: Secondary Hyperparathyroidism; End-Stage Renal Disease
Intervention: Drug: Paricalcitol
Sponsors: Abbott; Abbott
Recruiting - verified May 2012 - Conditions: Pancreatic Cancer; Adenocarcinoma; Pancreatic Neoplasms
Intervention: Drug: FOLFIRINOX, IPI-926
Sponsors: University of California, San Francisco; University of California, San Francisco; Infinity Pharmaceuticals, Inc.
Recruiting - verified March 2012 - Condition: Crohn's Disease
Interventions: Dietary Supplement: Vitamin D3; Other: Placebo
Sponsors: University of Dublin, Trinity College; University of Dublin, Trinity College; Irish Research Council for Science, Engineering and Technology
Not yet recruiting - verified June 2011 - Condition: Colorectal Cancer
Interventions: Drug: FOLFIRI regimen; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: liposome-encapsulated irinotecan hydrochloride PEP02; Genetic: polymorphism analysis; Other: pharmacogenomic studies; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Recruiting - verified June 2011 - Condition: Exercise and Non-exercise Effect Upon Vitamins E and C
Interventions: Dietary Supplement: Vitamin E and Vitamin C; Drug: placeboes
Sponsors: USDA Grand Forks Human Nutrition Research Center; USDA Grand Forks Human Nutrition Research Center
Recruiting - verified July 2011 - Condition: Autistic Disorder
Intervention: Drug: Vitamin D3
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Autism Speaks
Not yet recruiting - verified May 2011 - Conditions: Urticaria; Angioedema; Hives; Swelling
Interventions: Drug: Vitamin D; Drug: Vitamin D
Sponsors: University of Nebraska; University of Nebraska
Not yet recruiting - verified June 2011 - Condition: Pancreatic Cancer
Intervention: Drug: Vitamin C
Sponsors: University of Kansas; Jeanne Drisko, MD, CNS, FACN; Lotte and John Hecht Memorial Foundation; University of Kansas
Recruiting - verified September 2011 - Condition: Type 1 Diabetes
Intervention: Drug: Cholecalciferol
Sponsors: Medical University of Graz; Medical University of Graz; Medical University of Vienna
Recruiting - verified February 2012 - Conditions: Pediatric Leukemia; Other Pediatric Cancers
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Dry Eye Syndromes
Intervention: Dietary Supplement: Vitamac® Tag and Nacht capsules
Sponsors: Medical University of Vienna; Medical University of Vienna
Not yet recruiting - verified May 2011 - Condition: Vascular Calcification
Interventions: Drug: oral alfacalcidol; Drug: no drug
Sponsors: Ramathibodi Hospital; Ramathibodi Hospital
Recruiting - verified May 2011 - Conditions: Hypertension; Left Ventricular Hypertrophy
Interventions: Dietary Supplement: cholecalciferol (Vitamin D); Dietary Supplement: Placebo
Sponsors: Wayne State University; Wayne State University; National Center on Minority Health and Health Disparities (NCMHD)
Recruiting - verified January 2012 - Conditions: Colon Cancer; Rectal Cancer
Intervention: Drug: Study Arm only (modified FOLFOX6)
Sponsors: Brown University; Debora G. Isdale; Memorial Hospital of Rhode Island; Rhode Island Hospital; The Miriam Hospital
Recruiting - verified May 2012 - Condition: Basal Cell Carcinoma
Interventions: Drug: Diclofenac; Drug: Diclofenac + Calcitriol; Drug: Calcitriol
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified January 2012 - Conditions: Uremia; Inflammation
Interventions: Drug: oral vitamin C; Drug: oral vitamin C
Sponsors: Peking University First Hospital; Peking University First Hospital
Recruiting - verified August 2011 - Modufolin (6R 5,10-Methylenetetrahydrofolate) and Pemetrexed for Neoadjuvant Rectal Cancer TreatmentCondition: Rectal Cancer
Interventions: Drug: [6R] 5,10-methylenetetrahydrofolate; Drug: Pemetrexed
Sponsors: Isofol Medical AB; Isofol Medical AB
Recruiting - verified July 2011 - Condition: Polycystic Ovary Syndrome
Intervention: Drug: folate-boosted 3 mg DRSP/20 μg EE-24/4 oral contraceptive
Sponsors: BC Women's Hospital & Health Centre; BC Women's Hospital & Health Centre; Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Recruiting - verified March 2012 - Condition: Colorectal Cancer
Interventions: Drug: mFOLFOX6 + BIBF 1120; Drug: mFOLFOX6+placebo
Sponsors: Martin-Luther-Universität Halle-Wittenberg; Martin-Luther-Universität Halle-Wittenberg; GALMED GmbH, Halle, Germany
Recruiting - verified April 2012 - Condition: Adenocarcinoma of Pancreas
Intervention: Drug: Irinotecan, Oxaliplatin, Leucovorin, 5-FU
Sponsors: University of Oklahoma; University of Oklahoma
Recruiting - verified February 2012 - Condition: Vitamin D Deficiency
Interventions: Dietary Supplement: cholecalciferol; Dietary Supplement: placebo
Sponsors: Children's Memorial Health Institute, Poland; Children's Memorial Health Institute, Poland; Nutricia Research Fundation
Recruiting - verified April 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Gastric Cancer
Interventions: Biological: cetuximab; Drug: cisplatin; Drug: fluorouracil; Drug: leucovorin calcium; Procedure: adjuvant therapy; Procedure: neoadjuvant therapy; Procedure: quality-of-life assessment; Procedure: therapeutic conventional surgery
Sponsors: National Cancer Institute (NCI); Federation Francophone de Cancerologie Digestive
Recruiting - verified December 2011 - Condition: Stomach Neoplasms
Intervention: Drug: S-1; Oxaliplatin; 5-Fu; Leucovorin Calcium
Sponsors: Zhejiang University; Zhejiang University
Recruiting - verified May 2011 - Conditions: Pregnancy Complications; Preeclampsia
Interventions: Drug: Folic Acid 4 mg; Drug: Placebo
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Conditions: Autoimmune Diseases; Systemic Inflammatory Process; Knee Pain Chronic; Osteoarthritis; Rheumatoid Arthritis
Interventions: Drug: Fish Oil; Drug: Vitamin D; Other: placebo pill
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Conditions: Atrial Fibrillation; Venous Thromboembolism; Heart Valve Disease; Surgery
Interventions: Drug: Double dose; Drug: Single dose, meaning the usual maintenance dose
Sponsors: McMaster University; McMaster University
Recruiting - verified February 2011 - Condition: Breast Cancer
Interventions: Drug: Celecoxib; Drug: Placebo; Drug: Cholecalciferol
Sponsors: University of North Dakota; University of North Dakota; Department of Defense
Recruiting - verified August 2011 - Conditions: Colorectal Cancer; KRAS Wildtype; After Resection of Liver Metastases
Interventions: Drug: Folic Acid; Drug: 5-FU; Drug: 5-FU; Drug: Oxaliplatin; Drug: Panitumumab; Drug: Panitumumab; Drug: Folic Acid; Drug: 5-FU; Drug: 5-FU; Drug: Oxaliplatin
Sponsors: Ludwig-Maximilians - University of Munich; Ludwig-Maximilians - University of Munich; Amgen
Not yet recruiting - verified May 2011 - Condition: Deviated Nasal Septum
Interventions: Drug: Pregabalin (Lyrica); Drug: Vitamin complex (placebo)
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified June 2011 - Conditions: Insulin Resistance; Obesity; Vitamin D25 Insufficiency
Interventions: Drug: Vitamin D drops; Drug: Placebo drops
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified June 2011 - Conditions: Infant, Very Low Birth Weight; Calcium Deficiency; Vitamin D Deficiency
Intervention: Dietary Supplement: 400 IU Cholecalciferol- Vitamin D Daily
Sponsors: Medical University of South Carolina; Medical University of South Carolina; National Center for Research Resources (NCRR)
Recruiting - verified November 2011 - Condition: Keratoconus
Interventions: Drug: UVA light and Riboflavin 0.1% Ophthalmic solution; Drug: Dextan and UVA light exposure
Sponsors: Avedro, Inc.; Avedro, Inc.
Not yet recruiting - verified June 2011 - Condition: Obesity
Intervention: Procedure: Longitudinal sleeve gastrectomy
Sponsors: University Hospital, Clermont-Ferrand; University Hospital, Clermont-Ferrand
Not yet recruiting - verified November 2011 - Condition: Allergic Contact Dermatitis
Intervention: Drug: Calcipotriol, Betamethasone, Calcipotriol & Betamethasone
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified August 2011 - Conditions: Primary Hyperparathyroidism; Hypercalcemia; Vitamin D Deficiency; Osteoporosis; Osteopenia
Interventions: Dietary Supplement: Placebo; Dietary Supplement: Vitamin D3
Sponsors: Columbia University; Columbia University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2011 - Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week PeriodConditions: Anemia; Vitamin D Deficiency
Intervention:
Sponsors: Avera McKennan Hospital & University Health Center; Avera McKennan Hospital & University Health Center
Not yet recruiting - verified March 2011 - Condition: Congestive Heart Failure
Interventions: Drug: Vitamin D; Drug: placebo
Sponsors: Heart and Diabetes Center North-Rhine Westfalia; Heart and Diabetes Center North-Rhine Westfalia
Recruiting - verified March 2011 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer
Interventions: Drug: FOLFOX regimen; Drug: carboplatin; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: paclitaxel
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Type 2 Diabetes; Vitamin D Deficiency
Interventions: Drug: Vitamin D2; Drug: Sugar pill
Sponsors: University of Alabama at Birmingham; Ambika Ashraf, M.D.
Recruiting - verified April 2012 - Conditions: Obesity, Morbid; Gastric Bypass
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Condition: Peripheral Arterial Disease
Interventions: Drug: Niacin/Laropiprant combination; Drug: Sugar pill
Sponsors: Bayside Health; Bayside Health; National Health and Medical Research Council, Australia
Recruiting - verified July 2011 - Conditions: Osteoporosis; Hypercalcemia of Malignancy; Hyperparathyroidism; Bone Diseases, Endocrine
Interventions: Drug: Parathyroid Hormone-related Protein (1-36); Drug: parathyroid hormone (1-34); Drug: PTH (1-34) and PTHrP (1-36)
Sponsors: University of Pittsburgh; University of Pittsburgh
Not yet recruiting - verified January 2012 - Condition: Pancreatic Cancer
Interventions: Genetic: polymorphism analysis; Other: immunologic technique; Other: laboratory biomarker analysis; Other: medical chart review
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Prostate Cancer
Interventions: Dietary Supplement: Vitamin D and Genistein; Other: Placebo
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; University of Alabama at Birmingham; University of Rochester; University of Minnesota - Clinical and Translational Science Institute; Lahey Clinic; Urology San Antonio
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Vitamin C; Drug: glyburide
Sponsors: Al-Neelain University; Al-Neelain University
Recruiting - verified November 2011 - Conditions: Renal Function; Endothelial Function; Blood Pressure; Overweight; Obesity
Interventions: Drug: Vitamin D ergocalciferol; Drug: Probenecid; Drug: Allopurinol; Drug: Placebo; Drug: Placebo
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Condition: Metastatic Colorectal Cancer
Interventions: Drug: FOLFOXIRI + Panitumumab; Drug: FOLFOXIRI
Sponsors: AIO-Studien-gGmbH; AIO-Studien-gGmbH; Amgen; WiSP Wissenschaftlicher Service Pharma GmbH
Recruiting - verified April 2011 - Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vitamin D Deficiency
Interventions: Dietary Supplement: Vitamin D and Calcium Citrate; Dietary Supplement: Placebo
Sponsors: Children's Hospital Los Angeles; Children's Hospital Los Angeles; The Leukemia and Lymphoma Society
Recruiting - verified September 2011 - Condition: Colon Cancer
Interventions: Drug: chemotherapy and GI-4000; Drug: GI-4000
Sponsors: Georgetown University; Georgetown University; GlobeImmune
Recruiting - verified February 2012 - Condition: Hypercholesterolemia
Intervention: Drug: Niacin/Laropiprant
Sponsors: Instituto Aragones de Ciencias de la Salud; Instituto Aragones de Ciencias de la Salud; Hospital Miguel Servet
Recruiting - verified February 2012 - Conditions: Iron Deficiency; Anemia
Intervention: Other: Food Fortification: labeled iron solutions
Sponsors: Swiss Federal Institute of Technology; Swiss Federal Institute of Technology; Université d'Abomey-Calavi
Recruiting - verified November 2011 - Condition: End-Stage Renal Disease
Interventions: Drug: Cholecalciferol; Drug: Placebo
Sponsors: Regional Hospital Holstebro; Regional Hospital Holstebro
Recruiting - verified December 2011 - Conditions: Liver Metastases; Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer
Interventions: Drug: oxaliplatin; Drug: leucovorin calcium; Drug: fluorouracil; Biological: bevacizumab; Procedure: therapeutic conventional surgery; Radiation: yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A; Other: laboratory biomarker analysis; Other: pharmacological study; Drug: irinotecan hydrochloride
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Vitamin D Deficiency; Renal Failure Chronic Requiring Hemodialysis
Interventions: Drug: Ergocalciferol; Drug: Placebo
Sponsors: Albany College of Pharmacy and Health Sciences; Albany College of Pharmacy and Health Sciences; Department of Veterans Affairs; Hortense and Louis Rubin Dialysis Centers; Satellite Healthcare
Recruiting - verified December 2011 - Condition: Colorectal Cancer Metastatic
Intervention: Drug: FOLFIRI + Cetuximab
Sponsors: Johannes Gutenberg University Mainz; Dr. Carl Schimanski
Recruiting - verified April 2012 - Condition: Peripheral Neuropathy
Intervention: Dietary Supplement: Alpha lipoic acid
Sponsors: Northwestern University; Northwestern University
Not yet recruiting - verified June 2011 - Condition: Metastatic Colorectal Cancer
Interventions: Drug: panitumumab; Drug: Randomization to No Panitumumab
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Amgen
Recruiting - verified March 2012 - Condition: Oral Mucositis (Ulcerative) Due to Radiation
Intervention: Drug: Dexpanthenol
Sponsors: Shaheed Beheshti Medical University; Shaheed Beheshti Medical University
Recruiting - verified June 2010 - Condition: Male Infertility
Interventions: Drug: Cholecalciferol and calcium; Other: Placebo
Sponsors: Rigshospitalet, Denmark; Rigshospitalet, Denmark
Recruiting - verified February 2011 - Conditions: Coronary Artery Disease; Dyslipidemias
Interventions: Drug: Extended release niacin/laropiprant; Drug: placebo
Sponsors: Hospital Italiano de Buenos Aires; Daniel A. Siniawski; Merck
Recruiting - verified October 2011 - Conditions: Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Stage II Esophageal Cancer
Interventions: Biological: panitumumab; Drug: oxaliplatin; Drug: leucovorin calcium; Drug: fluorouracil; Radiation: radiation therapy; Procedure: therapeutic conventional surgery; Other: laboratory biomarker analysis; Other: high performance liquid chromatography; Genetic: DNA analysis; Genetic: polymorphism analysis; Other: pharmacological study; Other: pharmacogenomic studies
Sponsors: University of Nebraska; University of Nebraska; National Cancer Institute (NCI)
Recruiting - verified July 2011 - Conditions: Gestational Diabetes; Gestational Hypertension
Interventions: Other: Placebo; Dietary Supplement: Folic Acid
Sponsors: Mike O'Callaghan Federal Hospital; Mike O'Callaghan Federal Hospital
Not yet recruiting - verified April 2012 - Condition: Vitamin D
Intervention:
Sponsors: Mike O'Callaghan Federal Hospital; Mike O'Callaghan Federal Hospital
Recruiting - verified April 2012 - Condition: HIV-associated Co-morbidities
Interventions: Dietary Supplement: conventional vitamin D treatment versus a tiered/titrated dosing strategy; Drug: tiered/titrated vitamin D treatment
Sponsors: Mount Sinai School of Medicine; Andrea D. Branch; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Conditions: Primary Hyperparathyroidism; Vitamin D Deficiency
Interventions: Dietary Supplement: 50,000 IU Vitamin D3; Dietary Supplement: 12,000 IU Vitamin D3; Dietary Supplement: Placebo
Sponsors: Columbia University; Columbia University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified October 2011 - Condition: Anorexia Nervosa
Interventions: Drug: RhIGF-1 with transdermal 17-beta estradiol; Drug: Placebo and transdermal 17-beta estradiol
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; The Hospital for Sick Children
Recruiting - verified February 2012 - Condition: Colorectal Cancer Metastatic
Interventions: Drug: Regorafenib (BAY 73-4506); Drug: FOLFIRI; Drug: Placebo; Drug: FOLFIRI
Sponsors: UNC Lineberger Comprehensive Cancer Center; UNC Lineberger Comprehensive Cancer Center; Bayer
Recruiting - verified April 2012 - Conditions: Hypovitaminosis D; Insulin Resistance; Obesity; Osteoporosis
Interventions: Dietary Supplement: Euro D and Ci-CalD; Dietary Supplement: Euro D, Ci-CalD
Sponsors: American University of Beirut Medical Center; American University of Beirut Medical Center; Hotel Dieu de France Hospital; Rafic Hariri University Hospital
Recruiting - verified February 2012 - Condition: Tuberculosis
Interventions: Dietary Supplement: Placebo; Dietary Supplement: Vitamin D3 (cholecalciferol)
Sponsors: University of California, San Diego; University of California, San Diego; Thrasher Research Fund
Recruiting - verified July 2011 - Condition: Breast Cancer
Intervention: Drug: Calcitriol
Sponsors: University of Rochester; University of Rochester
Recruiting - verified August 2011 - Conditions: Heart Failure; Vitamin D Deficiency
Interventions: Drug: Cholecalciferol; Drug: Placebo
Sponsors: Medical University of Graz; Medical University of Graz
Recruiting - verified February 2012 - Conditions: Congestive Heart Failure; Ischemic Cardiomyopathy
Intervention: Dietary Supplement: Micronutrients
Sponsors: Phoenix VA Health Care System; Phoenix VA Health Care System
Recruiting - verified November 2011 - Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: Cholecaciferol (Vigantol oil) plus interferon beta-1a (Rebif®); Drug: Placebo plus interferon beta-1a (Rebif®); Biological: Interferon beta-1a (Rebif®) alone
Sponsors: Merck KGaA; Merck KGaA
Recruiting - verified January 2012 - Condition: Liver Diseases
Interventions: Drug: Intralipid 20%®; Drug: OMEGAVEN 10%®
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified January 2011 - Condition: Recurrent or Metastatic Gastric Cancer
Interventions: Drug: SP; Drug: FL/Tax; Drug: FL/Doc; Drug: FOLFOX
Sponsors: Yonsei University; Yonsei University
Recruiting - verified August 2011 - Condition: Sickle Cell Disease
Intervention: Drug: Vitamin D3
Sponsors: Columbia University; Columbia University
Recruiting - verified January 2012 - Condition: Metastatic Colorectal Cancer
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: irinotecan hydrochloride; Biological: bevacizumab; Biological: cetuximab; Drug: capecitabine; Genetic: mutation analysis; Genetic: gene expression analysis; Other: laboratory biomarker analysis; Other: immunohistochemistry staining method; Genetic: nucleic acid sequencing; Genetic: protein expression analysis; Genetic: polymerase chain reaction; Genetic: DNA analysis
Sponsors: Fox Chase Cancer Center; Fox Chase Cancer Center; National Cancer Institute (NCI)
Recruiting - verified October 2011 - Conditions: Cognitive/Functional Effects; Colorectal Cancer; Neurotoxicity
Interventions: Biological: bevacizumab; Drug: capecitabine; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI); Cancer and Leukemia Group B
Recruiting - verified February 2012 - Condition: Chronic Hepatitis C
Intervention:
Sponsors: Avera McKennan Hospital & University Health Center; Avera McKennan Hospital & University Health Center
Recruiting - verified January 2011 - Conditions: Vitamin B12 Deficiency; Folic Acid Deficiency
Intervention: Other: Blood Sample
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified March 2012 - Condition: Oxaliplatin Refractory/Intolerant KRAS Mutant Colorectal Cancer
Interventions: Biological: REOLYSIN; Drug: Irinotecan; Drug: Leucovorin; Drug: Fluorouracil (5-FU)
Sponsors: Oncolytics Biotech; Oncolytics Biotech; Montefiore Medical Center
Recruiting - verified December 2011 - Condition: Insulin Sensitivity
Interventions: Drug: Ergocalciferols; Drug: Placebo
Sponsors: Texas Tech University Health Sciences Center; Texas Tech University Health Sciences Center
Recruiting - verified December 2010 - Condition: Non Alcoholic Steatohepatitis
Interventions: Drug: Vitamin E plus Pentoxiphyllin; Drug: Vitamin E
Sponsors: Institute of Liver and Biliary Sciences, India; Institute of Liver and Biliary Sciences, India
Not yet recruiting - verified November 2011 - Condition: Rectal Cancer
Interventions: Drug: 5-FU with leucovorin; Drug: TS-1 with Irinotecan
Sponsors: Yonsei University; Yonsei University
Recruiting - verified March 2012 - Condition: Melanoma
Interventions: Drug: Vitamin D3 ( Colecalciferol); Other: placebo
Sponsors: European Institute of Oncology; European Institute of Oncology
Recruiting - verified August 2011 - Conditions: Schizophrenia; Negative Symptoms
Interventions: Drug: mirtazapine and folic acid; Drug: mirtazapine, folic acid placebo; Drug: mirtazapine placebo, folic acid; Drug: mirtazapine placebo, folic acid placebo
Sponsors: Capital Medical University; Capital Medical University
Recruiting - verified June 2011 - Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint ReplacementsConditions: Edematous; Synovitis; Foreign Body Reaction; Osteolysis
Interventions: Drug: Placebo; Drug: Apatone®B
Sponsors: Summa Health System; Summa Health System; Crystal Clinic Orthopaedic Center LLC
Recruiting - verified April 2012 - Conditions: RDS; Infant, Newborn; Vitamin A; Surfactant
Interventions: Drug: surfactant; Drug: surfactant+vitamin A
Sponsors: Third Military Medical University; Third Military Medical University
Not yet recruiting - verified November 2010 - Condition: Leukemia
Interventions: Biological: alemtuzumab; Drug: cyclophosphamide; Drug: cytarabine; Drug: dasatinib; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: etoposide phosphate; Drug: fludarabine phosphate; Drug: leucovorin calcium; Drug: melphalan; Drug: mercaptopurine; Drug: methotrexate; Drug: vincristine sulfate; Genetic: polymerase chain reaction; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: autologous hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Vitamin D3; Drug: Ciclesonide
Sponsors: Milton S. Hershey Medical Center; Milton S. Hershey Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Chronic Kidney Disease (CKD)
Interventions: Dietary Supplement: Dietary supplement; Dietary Supplement: Vitamin D; Dietary Supplement: Vitamin D
Sponsors: University of British Columbia; University of British Columbia; The Kidney Foundation of Canada; Pfizer
Recruiting - verified February 2012 - Conditions: Hypertension; Vitamin D Deficiency; Pre-Hypertension
Intervention: Dietary Supplement: vitamin D3 (cholecalciferol)
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; DiaSorin Inc
Recruiting - verified January 2012 - Conditions: Depression; PCOS
Interventions: Dietary Supplement: Inositol; Dietary Supplement: Placebo
Sponsors: AGUNCO Obstetrics and Gynecology Centre; AGUNCO Obstetrics and Gynecology Centre; Centro Clinico Colle Cesarano Tivoli Rome Italy
Recruiting - verified June 2011 - Condition: Metabolic Syndrome
Interventions: Drug: Vitamin D3; Behavioral: Lifestyle advice
Sponsors: University of Ioannina; University of Ioannina
Recruiting - verified November 2010 - Conditions: Diabetic Nephropathy; Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
Sponsors: The Nazareth Hospital, Israel; The Nazareth Hospital, Israel; Western Galilee Hospital-Nahariya
Not yet recruiting - verified March 2012 - Conditions: Hyperlipoproteinemia; Metabolic Syndrome
Intervention: Drug: Niacin/ Laropiprant
Sponsors: Ludwig-Maximilians - University of Munich; Ludwig-Maximilians - University of Munich
Recruiting - verified March 2012 - Conditions: Atopic Dermatitis; Vitamin D Deficiency; Asthma
Intervention:
Sponsors: Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital and Health System Foundation, Wisconsin
Recruiting - verified July 2011 - Conditions: Oxidative Stress; Inflammation; Aging; Dementia; Pain
Intervention: Dietary Supplement: secoisolariciresinol diglucoside
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatchewan Health Research Foundation
Recruiting - verified October 2011 - Conditions: Low Birth Weight; Preterm Birth
Intervention: Other: Food
Sponsors: Children's Hospital & Research Center Oakland; Children's Hospital & Research Center Oakland
Recruiting - verified August 2011 - Conditions: Stomach Cancer; Esophageal Cancer
Interventions: Biological: Ramucirumab; Drug: Placebo; Drug: Oxaliplatin; Drug: Leucovorin; Drug: 5-Fluorouracil
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Obesity; Short Stature
Interventions: Drug: Niacin; Drug: Placebo
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified April 2012 - Condition: Heart Failure
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: University of Michigan; University of Michigan
Recruiting - verified March 2012 - Conditions: Renal Dialysis; Vitamin D Deficiency
Intervention: Dietary Supplement: Ergocalciferol (Vitamin D)
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Patients With Primary Hyperparathyroidism (PHPT)
Intervention:
Sponsors: Postgraduate Institute of Medical Education and Research; Postgraduate Institute of Medical Education and Research
Recruiting - verified June 2011 - Condition: Spinal Cord Injury (SCI)
Intervention: Drug: L-Carnitine
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - verified November 2011 - Condition: Breast Cancer
Interventions: Dietary Supplement: vitamin D; Other: placebo
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Adenocarcinoma of the Esophagus; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Stage IV Esophageal Cancer; Stage IV Gastric Cancer
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: everolimus; Other: laboratory biomarker analysis; Other: immunohistochemistry staining method; Genetic: microarray analysis
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Metastatic Breast Cancer
Interventions: Drug: Eniluracil; Drug: 5-Fluorouracil; Drug: Leucovorin; Drug: Capecitabine
Sponsors: Adherex Technologies, Inc.; Adherex Technologies, Inc.
Recruiting - verified August 2011 - Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Periampullary Adenocarcinoma
Interventions: Drug: AZD2171; Drug: mFOLFOX6
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Primary Hypercholesterolemia; Mixed Dyslipidemia
Interventions: Drug: Extended-release niacin/laropiprant (ERN/LRPT); Drug: Placebo
Sponsors: Merck; Merck
Recruiting - verified April 2012 - Condition: Cured Primary Hyperparathyroidism, Concommitant Osteopenia or Osteoporosis
Interventions: Drug: Strontium Ranelate + Ca/Vitamin-D; Drug: Placebo
Sponsors: Medical University of Vienna; Medical University of Vienna; National Bank of Austria
Recruiting - verified April 2010 - Condition: HIV/AIDS
Intervention: Dietary Supplement: Multivitamin supplements B,C and E
Sponsors: Harvard School of Public Health; Harvard School of Public Health; Makerere University; Infectious Disease Institute, Kampala, Uganda
Recruiting - verified January 2012 - Conditions: Hypercholesterolemia; Mixed Dyslipidemia
Intervention: Drug: Niacin (+) laropiprant
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Colorectal Cancer
Interventions: Drug: Panitumumab; Drug: Oxaliplatin; Drug: Irinotecan; Drug: Leucovorin; Drug: 5-Fluorouracil
Sponsors: Sarah Cannon Research Institute; Sarah Cannon Research Institute; Amgen
Recruiting - verified July 2011 - Conditions: Asthma; Allergic Rhinitis
Interventions: Dietary Supplement: Lipoic acid; Dietary Supplement: Placebo capsule
Sponsors: Centro Universitario de Ciencias de la Salud, Mexico; Centro Universitario de Ciencias de la Salud, Mexico; Hospital Civil Juan I. Menchaca; National Council of Science and Technology, Mexico
Recruiting - verified February 2011 - Conditions: Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis; Intermediate Saphenous Vein Graft Lesions
Intervention: Drug: extended-release niacin (Niaspan)
Sponsors: North Texas Veterans Healthcare System; North Texas Veterans Healthcare System; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2011 - Condition: Congenital Malformations
Interventions: Drug: folic acid; Drug: folic acid
Sponsors: Azienda Ospedaliera Universitaria Integrata Verona; Azienda Ospedaliera Universitaria Integrata Verona; International Centre of Birth Defects
Recruiting - verified January 2012 - Condition: Diabetic Kidney Disease
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: Medical University of South Carolina; Medical University of South Carolina
Recruiting - verified October 2010 - Condition: Migraine
Interventions: Drug: Simvastatin; Dietary Supplement: Vitamin D; Other: Placebo
Sponsors: Beth Israel Deaconess Medical Center; Rami Burstein
Recruiting - verified January 2012 - Conditions: Renal Transplant; Secondary Hyperparathyroidism
Interventions: Drug: Paricalcitol; Drug: Standard therapy
Sponsors: Mario Negri Institute for Pharmacological Research; Mario Negri Institute for Pharmacological Research
Recruiting - verified June 2011 - Condition: Malaria
Interventions: Dietary Supplement: Folic Acid; Dietary Supplement: Folic Acid and Iron
Sponsors: Liverpool School of Tropical Medicine; Liverpool School of Tropical Medicine; Institute of Tropical Medicine, Belgium; University of Manchester; Institut de Recherche en Sciences de la Sante-Direction Regionale de l'Ouest; Centre Muraz; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified October 2011 - Condition: Acute Coronary Syndrome
Interventions: Behavioral: Community Health Worker, VITA Tool; Other: No intervention
Sponsors: St. John's Research Institute; St. John's Research Institute; National Heart and Lung Institute
Not yet recruiting - verified July 2011 - Condition: Advanced Non-Squamous Non-Small Cell Lung Cancer
Interventions: Drug: Docetaxel/cisplatin; Drug: Pemetrexed/cisplatin
Sponsors: Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Taiwan Chest Disease Association
Recruiting - verified September 2010 - Condition: Multiple Sclerosis
Intervention: Dietary Supplement: Cholecalciferol (Vitamin D3)
Sponsors: Merck KGaA; Merck KGaA; Merck Serono S.A.S, France
Recruiting - verified April 2012 - Conditions: Rectal Cancer; Colon Cancer; Metastasis; Adenocarcinoma
Interventions: Drug: Hydroxychloroquine; Drug: Oxaliplatin; Drug: Leucovorin; Drug: 5-fluorouracil; Drug: 5-fluorouracil; Drug: Bevacizumab
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified May 2012 - Condition: Spinal Cord Injury
Intervention: Other: Exercise
Sponsors: University of Miami; University of Miami
Recruiting - verified November 2011 - Condition: Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab + Oxaliplatin + 5FU/FA; Drug: Oxaliplatin + 5FU/FA
Sponsors: Merck KGaA; Merck KGaA
Recruiting - verified February 2012 - Condition: Smoking Addiction
Interventions: Drug: Placebo; Drug: Varenicline
Sponsors: The Mind Research Network; The Mind Research Network; National Institute on Drug Abuse (NIDA)
Recruiting - verified November 2011 - Conditions: Mucinous Adenocarcinoma of the Rectum; Stage IIA Rectal Cancer; Stage IIB Rectal Cancer; Stage IIC Rectal Cancer; Stage IIIB Rectal Cancer; Stage IIIC Rectal Cancer
Interventions: Drug: paricalcitol; Radiation: radiation therapy; Other: laboratory biomarker analysis; Drug: fluorouracil
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Postural Tachycardia Syndrome
Interventions: Drug: Losartan; Drug: Ascorbic Acid (Vitamin C); Drug: Normal Saline
Sponsors: New York Medical College; New York Medical College
Recruiting - verified December 2011 - Condition: Leukemia
Interventions: Drug: cyclophosphamide; Drug: cytarabine; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: thioguanine; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Coronary Artery Disease; Postprandial Hyperglycemia; Vitamin D Deficiency
Intervention: Drug: vitamin D
Sponsors: Medical University of Graz; Medical University of Graz
Recruiting - verified March 2012 - Condition: Multiple Sclerosis, Chronic Progressive
Interventions: Drug: lipoic acid; Drug: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Oregon Health and Science University
Recruiting - verified March 2012 - Conditions: Healthy; Vitamin D Deficiency
Interventions: Dietary Supplement: ergocalciferol; Other: placebo pill
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Condition: Advanced Cancers
Interventions: Drug: Lenalidomide; Drug: Bevacizumab; Drug: Sorafenib; Drug: Temsirolimus; Drug: Lenalidomide; Drug: Oxaliplatin; Drug: Leucovorin; Drug: 5-fluorouracil
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Celgene Corporation
Recruiting - verified May 2012 - Conditions: Vitamin D Deficiency; End-stage Renal Disease
Intervention: Drug: Cholecalciferol
Sponsors: Heeger, Peter, M.D.; Heeger, Peter, M.D.; National Kidney Foundation
Recruiting - verified June 2011 - Condition: Metastatic Colorectal Cancer
Intervention: Drug: FOLFIRI, Avastin, Irinotecan
Sponsors: University of Chicago; University of Chicago; National Institute for Cancer Research, Italy
Recruiting - verified June 2011 - Condition: Chronic Kidney Disease Stage 3 and 4
Interventions: Drug: Ergocalciferol; Drug: Cholecalciferol
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Recruiting - verified January 2012 - Condition: Aging
Intervention: Dietary Supplement: Vitamins C, E, and alpha lipoic acid
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of Utah
Not yet recruiting - verified January 2012 - Condition: Colorectal Cancer
Interventions: Biological: Ramucirumab; Drug: Irinotecan; Biological: Placebo; Drug: Folinic Acid; Drug: 5-Fluorouracil
Sponsors: Eli Lilly and Company; Eli Lilly and Company; ImClone LLC
Recruiting - verified May 2012 - Condition: Vitamin D Deficiency
Interventions: Drug: vitamin D3 1000 IU orally daily for 5 months; Drug: vitamin D3 3000 IU orally daily for 5 months; Drug: vitamin D3 5000 IU orally daily for 5 months; Drug: Placebo orally daily for 5 months
Sponsors: King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center
Recruiting - verified December 2011 - Conditions: Diabetes Mellitus; Vitamin D Deficiency
Interventions: Drug: vitamin D3 2000 IU; Drug: vitamin D3 5000 IU; Drug: Placebo
Sponsors: King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center
Recruiting - verified December 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center
Recruiting - verified December 2011 - Condition: Vitamin D Deficiency
Interventions: Drug: ergocalciferol 2000 IU orally, daily; Drug: ergocalciferol 25000 IU oraly every 2 weeks; Drug: ergocalciferol 50000 IU orally every 4 weeks; Drug: ergocal1000 IU & cholecal 1000 IU orally daily; Drug: cholecalciferol 2000 IU orally daily; Drug: Cholecalciferol 25000 IU orally every 2 weeks; Drug: Cholecalciferol 50000 orally every 4 weeks; Drug: placebo orally everyday
Sponsors: King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center
Recruiting - verified December 2011 - Condition: Vitamin D Deficiency in Older Persons
Interventions: Dietary Supplement: loading dose Vitamin D and 50.000 IU vit D3/month; Dietary Supplement: loading dose and 25.000 IU vit D3/month; Dietary Supplement: Vitamin D 800 IU /day
Sponsors: Rijnstate Hospital; Rijnstate Hospital
Recruiting - verified August 2011 - Conditions: Frail Elderly; Vitamin d Deficiency
Interventions: Dietary Supplement: vitamin D; Dietary Supplement: placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Conditions: Schizophrenia; Schizoaffective Disorder
Interventions: Dietary Supplement: Vitamin D3; Dietary Supplement: Vitamin D3
Sponsors: Bronx Psychiatric Center; Bronx Psychiatric Center
Recruiting - verified April 2012 - Condition: Fractures
Interventions: Drug: Teriparatide; Drug: Placebo
Sponsors: Ohio Orthopedic Center of Excellence; Ohio Orthopedic Center of Excellence; Eli Lilly and Company
Recruiting - verified July 2011 - Conditions: Venous Thromboembolism; Neoplasms
Interventions: Drug: low molecular weight heparin; Drug: vitamin K antagonists
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified January 2012 - Conditions: Colorectal Cancer; Diarrhea; Neutropenia
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: UNC Lineberger Comprehensive Cancer Center; UNC Lineberger Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Iron Absorption in Presence of Polyphenols
Intervention: Dietary Supplement: labeled iron solutions
Sponsors: Swiss Federal Institute of Technology; Swiss Federal Institute of Technology
Recruiting - verified February 2012 - Conditions: Dialysis; Cardiovascular Disease; Atherosclerosis; Inflammation
Intervention: Drug: Extended Release Nicotinic Acid (Niaspan)
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified June 2011 - Condition: Coronary Artery Occlusive Disease
Interventions: Drug: liothyronine sodium; Drug: placebo
Sponsors: Yonsei University; Yonsei University
Recruiting - verified September 2011 - Condition: Colorectal Cancer
Intervention: Drug: Vitamin D
Sponsors: University of British Columbia; University of British Columbia; Lotte and John Hecht Memorial Foundation
Recruiting - verified November 2011 - Conditions: Growth; Low Weight; Low Height
Interventions: Dietary Supplement: Nutritional supplementation formula; Dietary Supplement: Placebo Comparator
Sponsors: Rabin Medical Center; Rabin Medical Center
Recruiting - verified December 2011 - Condition: Gastric Cancer
Interventions: Drug: 5-Fluorouracil; Drug: Leucovorin; Drug: Oxaliplatin; Drug: Docetaxel; Drug: Epirubicin; Drug: Cisplatin; Drug: 5-fluorouracil
Sponsors: Krankenhaus Nordwest; Krankenhaus Nordwest
Recruiting - verified March 2012 - Conditions: Secondary Hyperparathyroidism; End Stage Renal Disease
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Colorectal Cancer
Interventions: Drug: celecoxib; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Other: placebo
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Keratoconus; Corneal Ectasia
Interventions: Drug: Riboflavin/Dextran; Drug: Hypotonic Riboflavin
Sponsors: Cornea and Laser Eye Institute; Cornea and Laser Eye Institute
Recruiting - verified November 2011 - Condition: Neonatal Vitamin A Supplementation
Intervention: Drug: Vitamin A
Sponsors: Society for Applied Studies; Society for Applied Studies; World Health Organization
Recruiting - verified April 2012 - Conditions: Gastric Bypass; Parathyroid Hormone
Interventions: Drug: Paricalcitol; Drug: Cholecalciferol; Drug: Placebo
Sponsors: William Beaumont Hospitals; William Beaumont Hospitals; Abbott
Recruiting - verified September 2011 - Conditions: Keratoconus; Post-Refractive Ectasia
Intervention: Device: UVX Light
Sponsors: Price Vision Group; Price Vision Group
Recruiting - verified April 2012 - Conditions: Cutaneous T-cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Primary Cutaneous Anaplastic Large Cell Lymphoma
Interventions: Drug: Pralatrexate Injection; Drug: Bexarotene Capsules; Dietary Supplement: Vitamin B12; Dietary Supplement: Folic Acid
Sponsors: Allos Therapeutics; Allos Therapeutics
Recruiting - verified January 2012 - Condition: Statin Myopathy
Interventions: Drug: CoEnzyme Q10; Drug: Placebo
Sponsors: Hartford Hospital; Hartford Hospital
Recruiting - verified January 2012 - Conditions: Secondary Hyperparathyroidism; End-Stage Renal Disease
Interventions: Drug: Paricalcitol; Drug: Calcitriol
Sponsors: Abbott; Abbott; North America Pediatric Renal Trials and Collaborative Studies (NAPRTCS)
Recruiting - verified January 2012 - Condition: Venous Thromboembolism
Interventions: Drug: Warfarin; Drug: Innohep®
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified February 2012 - Condition: Vitamin B6 Deficiency
Intervention: Dietary Supplement: Vitamin B6
Sponsors: University of Florida; University of Florida
Recruiting - verified March 2012 - Conditions: Duchenne Muscular Dystrophy; Becker Muscular Dystrophy; Limb Girdle Muscular Dystrophy
Intervention: Drug: Coenzyme Q10 and Lisinopril
Sponsors: Cooperative International Neuromuscular Research Group; Cooperative International Neuromuscular Research Group; Department of Defense
Recruiting - verified November 2011 - Conditions: Malaria; Low Birth Weight; Anemia; Perinatal Mortality
Interventions: Dietary Supplement: Vitamin A; Dietary Supplement: Zinc; Other: Placebo
Sponsors: Harvard School of Public Health; Harvard School of Public Health; Muhimbili University of Health and Allied Sciences
Recruiting - verified January 2012 - Condition: Vitamin D Deficiency
Interventions: Drug: Vitamin D; Drug: Vitamin D3; Drug: Vitamin D
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Condition: Unresectable Biliary Tract Cancer
Intervention: Drug: 5-fluorouracil, leucovorin, oxaliplatin
Sponsors: Chung-Ang University; Chung-Ang University; Gyeongsang National University Hospital; Dong-A University Hospital; Samsung Medical Center
Recruiting - verified April 2010 - Conditions: Parkinson Disease; Accidental Falls
Interventions: Dietary Supplement: Vitamin D; Dietary Supplement: calcium; Other: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Oregon Health and Science University
Recruiting - verified January 2012 - Condition: Pancreatic Neoplasms
Interventions: Drug: Leucovorin; Drug: OXALIPLATIN; Drug: Capecitabine; Drug: 5-Fluorouracil
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified February 2012 - Condition: Bacterial Infections
Interventions: Dietary Supplement: fortification with iron and micronutrients; Dietary Supplement: Sprinkles
Sponsors: Swiss Federal Institute of Technology; Swiss Federal Institute of Technology; University of KwaZulu; University of Nairobi
Recruiting - verified April 2012 - Conditions: Keratoconus; Corneal Ectasia
Intervention: Drug: Riboflavin
Sponsors: Cornea and Laser Eye Institute; Cornea and Laser Eye Institute
Recruiting - verified September 2011 - Conditions: Age-related Macular Degeneration; Age-related Maculopathy
Interventions: Other: Observational-1; Other: Observational-2
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Jules Stein Eye Institute; University of Pittsburgh; National Eye Institute (NEI)
Recruiting - verified March 2012 - Condition: the Effect of MTHFR C677T on Folate Metabolism
Interventions: Dietary Supplement: folic acid plus B6 and B12; Dietary Supplement: folic acid
Sponsors: Saarland University; Saarland University; Dr. Eckert from the Geriatrics Rehaklinik, St. Ingbert
Recruiting - verified April 2009 - Conditions: Stage 2-5 Chronic Kidney Disease; Predialysis
Intervention:
Sponsors: National University, Singapore; National University, Singapore; National Kidney Foundation, Singapore
Recruiting - verified May 2012 - Condition: Pressure Ulcers
Interventions: Dietary Supplement: Enriched nutrition formula; Dietary Supplement: Control formula
Sponsors: Azienda Ospedaliero Universitaria Maggiore della Carita; Azienda Ospedaliero Universitaria Maggiore della Carita; NUTRICIA Italia
Recruiting - verified February 2012 - Conditions: brca1 Mutation Carrier; brca2 Mutation Carrier; Breast Cancer
Interventions: Dietary Supplement: cholecalciferol; Other: placebo
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Myocardial Infarction
Interventions: Drug: Vitamin C; Drug: Placebo
Sponsors: University of Roma La Sapienza; University of Roma La Sapienza
Recruiting - verified March 2010 - Conditions: Hemophilia A; Hemophilia B; Vitamin D Deficiency
Intervention: Dietary Supplement: Vitamin D and calcium
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; CSL Behring
Recruiting - verified March 2010 - Condition: Schizophrenia
Interventions: Other: Placebo; Other: L-methylfolate
Sponsors: Pamlab, L.L.C.; Pamlab, L.L.C.; Massachusetts General Hospital
Recruiting - verified April 2012 - Condition: Advanced Solid Tumors
Interventions: Dietary Supplement: calcitriol; Drug: cisplatin; Drug: gemcitabine hydrochloride; Other: pharmacological study
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute
Recruiting - verified March 2012 - Condition: Pulmonary Arterial Hypertension
Intervention: Other: Nutritional Supplement Coenzyme Q-10
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Recruiting - verified May 2012 - Condition: Prostatic Neoplasms
Intervention: Drug: Ascorbic Acid (Vitamin C)
Sponsors: Copenhagen University Hospital at Herlev; Copenhagen University Hospital at Herlev; Rigshospitalet, Denmark; University of Copenhagen
Recruiting - verified September 2011 - Conditions: Kidney Insufficiency; Secondary Hyperparathyroidism
Intervention: Drug: Zemplar (paricalcitol)
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Septic Shock
Interventions: Drug: D5W; Drug: Thiamine
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified July 2011 - Condition: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons
Interventions: Other: questionnaires; Biological: blood sampling; Other: clinical evaluation; Other: Dermatology evaluation; Other: Bone evaluation
Sponsors: University Hospital, Ghent; University Hospital, Ghent
Recruiting - verified December 2011 - Condition: Healthy
Intervention: Dietary Supplement: Vitamin D
Sponsors: Rabin Medical Center; Rabin Medical Center
Recruiting - verified July 2011 - Condition: Breast Cancer
Interventions: Drug: Placebo; Drug: Denosumab
Sponsors: Amgen; Amgen; Daiichi Sankyo Inc.
Recruiting - verified May 2012 - Condition: Rectal Neoplasms
Intervention: Other: 5 days of radiation followed by FOLFOX chemotherapy given every other week for 6 weeks
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Intervention: Drug: lipoic acid and fish oil concentrate
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified May 2012 - Conditions: Adenocarcinoma of the Pancreas; Pancreatic Cancer; Stage III Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride; Drug: leucovorin calcium; Drug: fluorouracil; Drug: nelfinavir mesylate; Radiation: stereotactic body radiation therapy; Radiation: hypofractionated radiation therapy; Procedure: therapeutic conventional surgery; Other: pharmacological study; Genetic: polymorphism analysis; Other: pharmacogenomic studies; Genetic: protein expression analysis
Sponsors: University of Nebraska; University of Nebraska; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Conditions: Hypophosphatemia, Familial; Rickets; Hyperphosphatemia
Interventions: Dietary Supplement: Alfacalcidol; phosphate.; Drug: Sevelamer
Sponsors: Haukeland University Hospital; Haukeland University Hospital
Recruiting - verified February 2012 - Conditions: Cancer; Cardiovascular Disease
Interventions: Dietary Supplement: vitamin D3; Dietary Supplement: omega-3 fatty acids (fish oil); Dietary Supplement: Vitamin D3 placebo; Dietary Supplement: Fish oil placebo
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); Office of Dietary Supplements (ODS); National Institute of Neurological Disorders and Stroke (NINDS); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified May 2012 - Condition: Cancer
Intervention: Dietary Supplement: vitamin C (ascorbic acid)
Sponsors: Jewish General Hospital; Jewish General Hospital
Recruiting - verified January 2010 - Condition: Anemia, Sickle Cell
Intervention: Drug: alpha-lipoic acid and acetyl-L-carnitine
Sponsors: Children's Hospital & Research Center Oakland; Children's Hospital & Research Center Oakland; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified August 2011 - Condition: Peritoneal Dialysis
Interventions: Drug: Bioimpedance and Vitamin D; Drug: Usual care and placebo; Drug: Usual care and Vitamin D; Device: Bioimpedance and Placebo
Sponsors: St. Joseph's Healthcare Hamilton; St. Joseph's Healthcare Hamilton; Population Health Research Institute
Recruiting - verified October 2011 - Condition: Colorectal Cancer
Interventions: Drug: RAD011; Drug: FOLFOX; Drug: Bevacizumab
Sponsors: University of Utah; University of Utah; Novartis
Recruiting - verified January 2012 - Condition: Autistic Disorder
Interventions: Drug: Methyl B12; Dietary Supplement: Placebo
Sponsors: University of California, San Francisco; University of California, San Francisco; University of California, Davis; Arkansas Children's Hospital Research Institute
Recruiting - verified March 2012 - Condition: Cognition
Intervention: Drug: Niaspan
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified November 2009 - Conditions: Birth Weight; Vitamin D Deficiency; Pregnancy
Interventions: Dietary Supplement: Cholecalciferol 35 µg per day; Other: placebo tablet; Dietary Supplement: Cholecalciferol (Vitamin D3) 70 µg
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified November 2011 - Condition: Skin Cancer
Interventions: Dietary Supplement: Green tea + vitamin C high dose; Dietary Supplement: Placebo capsule
Sponsors: University of Manchester; University of Manchester; University of Leeds; University of Bradford
Recruiting - verified November 2011 - Conditions: C-reactive Protein; Inflammation; Obesity; Oxidative Stress
Intervention: Dietary Supplement: Vitamin C (ascorbic acid)
Sponsors: University of California, Berkeley; University of California, Berkeley; Kaiser Permanente
Recruiting - verified June 2011 - Conditions: Chronic Renal Insufficiency; Proteinuria
Interventions: Drug: Vitamin D; Other: Placebo
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University
Recruiting - verified October 2011 - Condition: Pulmonary Hypertension
Intervention: Drug: Warfarin
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Conditions: Pain; Weakness; Cramps; Myalgia; Side Effects of Statins
Interventions: Dietary Supplement: Coenzyme Q10; Other: Placebo
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified June 2011 - Conditions: Chronic Kidney Disease; Vitamin D Deficiency
Interventions: Drug: Ergocalciferol; Drug: Calcitriol
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Kidney Foundation
Recruiting - verified July 2011 - Conditions: Multiple Sclerosis; Vitamin D Deficiency
Interventions: Dietary Supplement: Cholecalciferol; Dietary Supplement: Cholecalciferol
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified June 2011 - Conditions: Vitamin D Deficiency; Secondary Hyperparathyroidism; Osteomalacia
Intervention: Drug: 25 OH vitamin D
Sponsors: Clalit Health Services; Clalit Health Services
Recruiting - verified December 2009 - Conditions: Back Pain; Hypovitaminosis D
Interventions: Drug: Vitamin D; Drug: Placebo
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center
Recruiting - verified December 2009 - Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939); Drug: Pharmacologic agents (e.g. LMWH/VKA/Fondaparinux/Aspirin and etc.)
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Dietary Supplement: Compound Natural Health Product; Dietary Supplement: Placebo
Sponsors: The Canadian College of Naturopathic Medicine; The Canadian College of Naturopathic Medicine; Health Canada; Centre for Addiction and Mental Health; SickKids Foundation
Not yet recruiting - verified October 2011 - Condition: Primary Myelofibrosis
Intervention: Drug: Dose Escalating Arsenic Trioxide plus ascorbic Acid
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; Cephalon
Recruiting - verified February 2012 - Conditions: Brain Cancer; Choroid Plexus Tumors
Interventions: Drug: Carboplatin; Drug: Cisplatin; Drug: Cyclophosphamide; Drug: Dactinomycin; Drug: Doxorubicin; Drug: Etoposide; Drug: Irinotecan; Drug: Leucovorin; Drug: Methotrexate; Drug: Temozolomide; Drug: Vincristine
Sponsors: Tufts Medical Center; Tufts Medical Center
Recruiting - verified April 2012 - Condition: Chronic Kidney Disease Stage 3 and 4
Interventions: Drug: Zemplar (paricalcitol) Capsules; Drug: Placebo capsules
Sponsors: Abbott; Abbott
Recruiting - verified May 2012 - Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed PatientsConditions: Chronic Renal Failure; Hemodialysis
Interventions: Drug: nicotinamide; Drug: sevelamer; Drug: cinacalcet
Sponsors: Centre Hospitalier Universitaire, Amiens; Centre Hospitalier Universitaire, Amiens
Recruiting - verified February 2012 - Condition: Dyslipidemia
Interventions: Drug: High-dose rosuvastatin; Drug: Statin plus fenofibrate; Drug: Statin plus niacin ER/laropiprant
Sponsors: University of Ioannina; University of Ioannina
Recruiting - verified November 2009 - Condition: Chronic Stable Plaque Psoriasis
Interventions: Drug: Clobex Spray; Drug: Vectical Ointment; Procedure: Excimer Laser
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Interventions: Dietary Supplement: Menaquinone-7 (Vitamin K2); Other: Placebo capsules
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; VitaK
Recruiting - verified October 2011 - Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: placebo; Drug: pioglitazone; Dietary Supplement: Vitamin E
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified February 2012 - Condition: Lymphoma, B-Cell
Interventions: Drug: Pralatrexate Injection; Dietary Supplement: Vitamin B12; Dietary Supplement: Folic Acid
Sponsors: Allos Therapeutics; Allos Therapeutics
Recruiting - verified October 2011 - Condition: Hyperglycemia
Interventions: Drug: 5% dextrose; Drug: vitamin C; Drug: Simvastatin; Drug: L-NMMA
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Condition: Multiple Sclerosis
Intervention: Dietary Supplement: Lipoic Acid
Sponsors: Portland VA Medical Center; Portland VA Medical Center; Oregon Health and Science University
Recruiting - verified January 2012 - Conditions: Coagulation; Bleeding; Thrombosis
Interventions: Drug: Phytonadione (Vitamin K1); Drug: Placebo
Sponsors: St. Joseph's Healthcare Hamilton; St. Joseph's Healthcare Hamilton; McMaster University; University of Western Ontario, Canada
Recruiting - verified March 2012 - Conditions: Pain; Soreness; Weakness; Fatigue
Interventions: Dietary Supplement: Co-enzyme Q-10; Dietary Supplement: Placebo
Sponsors: Stony Brook University; Stony Brook University
Recruiting - verified August 2011 - Condition: Low Cardiac Output Syndrome
Interventions: Drug: Levosimendan; Drug: placebo
Sponsors: Università Vita-Salute San Raffaele; Università Vita-Salute San Raffaele
Recruiting - verified January 2012 - Condition: Pancreatic Neoplasms
Intervention: Drug: Vitamin E δ-Tocotrienol
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Age-related Macular Degeneration
Intervention: Dietary Supplement: Ocean Nutrition MEG3 4020EE product
Sponsors: University of Alberta; Yves Sauve; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified November 2011 - Conditions: Heart Diseases; Diabetes Mellitus, Type 2; Behavior; Motivation
Intervention: Behavioral: Intervention Group (IG)
Sponsors: Freie Universität Berlin; Freie Universität Berlin; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified June 2011 - Conditions: Diabetes Type 2; Hypertension
Interventions: Drug: acetyl-L-carnitine/statin (simvastatin); Drug: placebo
Sponsors: Mario Negri Institute for Pharmacological Research; Mario Negri Institute for Pharmacological Research; Sigma Tau Pharmaceuticals, Inc.
Recruiting - verified June 2011 - Conditions: Vitamin D Deficiency; Hypertension
Interventions: Drug: aliskiren (Tekturna); Dietary Supplement: cholecalciferol (Vitamin D3); Dietary Supplement: Placebo
Sponsors: University of Connecticut Health Center; University of Connecticut Health Center; Novartis
Recruiting - verified December 2011 - Conditions: Primary Hyperparathyroidism; Bone Metabolism
Intervention: Drug: Calcium and vitamin D
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified April 2012 - Condition: Breast Cancer
Interventions: Dietary Supplement: Coenzyme Q10; Dietary Supplement: Coenzyme Q10 Placebo
Sponsors: Columbia University; Columbia University; National Institutes of Health (NIH)
Recruiting - verified October 2011 - Condition: Acute Thrombosis of Deep Veins of Proximal Lower Extremity
Intervention: Device: Ekos endowave system thrombolysis
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified July 2010 - Condition: Myocardial Infarction
Interventions: Drug: Mangafodipir; Drug: Placebo
Sponsors: PledPharma AB; PledPharma AB
Recruiting - verified June 2011 - Condition: Heart Failure
Interventions: Dietary Supplement: Vitamin B1; Dietary Supplement: Placebo
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto; Heart and Stroke Foundation of Ontario
Recruiting - verified September 2011 - Condition: Colorectal Neoplasms
Interventions: Drug: 5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab; Drug: 5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab; Drug: 5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab
Sponsors: AIO-Studien-gGmbH; AIO-Studien-gGmbH; Roche Pharma AG
Recruiting - verified October 2011 - Conditions: CIDP; Chronic Inflammatory Demyelinating Polyneuropathy
Intervention: Drug: lipoic acid
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Collins Medical Trust
Recruiting - verified February 2012 - Condition: Prostate Cancer
Interventions: Drug: vitamin D3; Drug: Placebo daily for one year
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Making Maternal Post-partum Vitamin A Supplementation Effective: The Role of Timing and InflammationCondition: Healthy Women Giving Birth to Singleton Infants
Intervention: Dietary Supplement: vitamin A
Sponsors: Institut de Recherche pour le Developpement; Institut de Recherche pour le Developpement; Thrasher Research Fund; University of Copenhagen; National Institute of Nutrition, Hanoi, Vietnam (implementation)
Recruiting - verified November 2011 - Condition: Mouth Neoplasms
Interventions: Drug: 1,25-dihydroxyvitamin D3; Drug: celecoxib; Drug: 1,25-dihydroxyvitamin D3 + celecoxib
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Heart Failure
Intervention:
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto; Canadian Foundation for Dietetic Research (CFDR)
Recruiting - verified September 2011 - Conditions: Metabolism; Fasting; Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions: Behavioral: Fasting; Behavioral: Fasting; Behavioral: Diet
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center
Recruiting - verified December 2011 - Condition: Breast Cancer
Interventions: Drug: Docetaxel + High dose Vitamin D2; Drug: Docetaxel + Standard dose Vitamin D2
Sponsors: King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center
Recruiting - verified December 2011 - Condition: Exercise-related Amenorrhea
Interventions: Drug: Transdermal 17Beta-estradiol, progesterone; Drug: Ethinyl Estradiol + Desogestrel; Dietary Supplement: Elemental Calcium and Vitamin D
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Gastric Cancer
Interventions: Drug: Oxaliplatin; Drug: Irinotecan; Drug: 5-Fluorouracil; Drug: Leucovorin; Procedure: Gastrectomy and/or metastasectomy
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Advanced Cancers
Interventions: Drug: HAI Oxaliplatin; Drug: 5-FU; Drug: Bevacizumab; Drug: Cetuximab; Drug: Leucovorin; Drug: 5-FU; Drug: Bevacizumab
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Conditions: Vitamin D Status; Secondary Hyperparathyroidism; Post-Menopause
Interventions: Drug: High Dose Vitamin D3; Drug: Low Dose Vitamin D3; Drug: Placebo; Drug: Placebo
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; National Institutes of Health (NIH)
Recruiting - verified November 2011 - Condition: Intracranial Hemorrhages
Intervention: Drug: Prothrombin complex concentrate (PCC); fresh frozen plasma (FFP)
Sponsors: University of Heidelberg; University of Heidelberg
Recruiting - verified November 2011 - Condition: Colon Cancer With Metastases to the Liver
Interventions: Device: LC bead loaded with Irinotecan; Drug: FOLFOX6 and Avastin
Sponsors: University of Louisville; University of Louisville; Biocompatibles UK Ltd
Recruiting - verified November 2011 - Condition: HIV Infections
Interventions: Drug: Alendronate; Drug: Alendronate placebo; Dietary Supplement: Calcium carbonate/vitamin D
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Condition: Tuberculosis
Interventions: Dietary Supplement: Vitamin D pill; Dietary Supplement: Placebo
Sponsors: Emory University; Emory University
Recruiting - verified June 2011 - Condition: Healthy
Interventions: Drug: Vitamin and mineral supplement; Drug: Vitamin and mineral supplement; Drug: Placebo; Drug: 100% Oxygen; Drug: Escherichia coli Endotoxin
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified June 2009 - Condition: Tardive Dyskinesia
Interventions: Drug: Pyridoxal 5'-Phosphate; Drug: Placebo
Sponsors: Medicure; Medicure
Recruiting - verified September 2011 - Condition: Infectious Keratitis
Interventions: Drug: riboflavin; Device: UVX Light
Sponsors: Price Vision Group; Price Vision Group; Cornea Research Foundation of America
Recruiting - verified April 2012 - Condition: Colorectal Cancer
Interventions: Dietary Supplement: vitamin E; Other: laboratory biomarker analysis
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey; National Cancer Institute (NCI)
Recruiting - verified October 2011 - Conditions: Cancer; Colon Cancer; Colorectal Cancer; Fever; Locally Advanced; Metastatic Colorectal Cancer; Neutropenia; Rectal Cancer
Interventions: Drug: Pegfilgrastim; Drug: Placebo
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Condition: Prostate Cancer
Interventions: Dietary Supplement: vitamin E; Procedure: sham intervention
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey; National Cancer Institute (NCI)
Recruiting - verified December 2011 - Condition: End Stage Renal Disease
Interventions: Drug: Ergocalciferol; Drug: Ergocalciferol; Other: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified April 2012 - Conditions: Autism; Severe Behavior Disorder
Interventions: Drug: placebo; Drug: glutathione; Drug: glutathione, vitamin C and N-acetylcysteine
Sponsors: University of Louisville; University of Louisville; Kosair Children's Hospital Foundation; Cumberland Pharmaceuticals
Recruiting - verified September 2011 - Condition: Biotin Deficiency
Interventions: Dietary Supplement: biotin; Dietary Supplement: biotin
Sponsors: University of Arkansas; University of Arkansas; University of Nebraska
Recruiting - verified January 2012 - Conditions: Adenocarcinoma of the Prostate; Stage I Prostate Cancer; Stage II Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer
Interventions: Dietary Supplement: cholecalciferol; Drug: Placebo Administration
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute
Recruiting - verified January 2012 - Condition: Non Small Cell Lung Cancer
Interventions: Drug: Pemetrexed (Alimta); Drug: Gefitinib (IRESSA)
Sponsors: Chinese Society of Lung Cancer; Chinese Society of Lung Cancer
Recruiting - verified June 2009 - Condition: Spinal Cord Injuries
Intervention: Device: Mechanical Stimulation with the Vibration Plate
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Kessler Foundation
Recruiting - verified January 2012 - Condition: Colorectal Neoplasms
Interventions: Drug: Sorafenib; Drug: Placebo; Drug: Oxaliplatin or Irinotecan; Drug: Leucovorin; Drug: 5-Fluorouracil
Sponsors: AIO-Studien-gGmbH; AIO-Studien-gGmbH
Recruiting - verified September 2011 - Conditions: Muscle Strength; Sarcopenia
Interventions: Dietary Supplement: Beta-hydroxy-Beta-methylbutyrate and/ or Vitamin D; Dietary Supplement: Placebo
Sponsors: Metabolic Technologies Inc.; Metabolic Technologies Inc.; Iowa State University; South Dakota State University
Recruiting - verified January 2012 - Condition: Colorectal Cancer
Interventions: Biological: bevacizumab; Drug: FOLFOX regimen; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: ursodiol; Genetic: RNA analysis; Genetic: gene expression analysis; Genetic: polymerase chain reaction; Genetic: western blotting; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: positron emission tomography (PET)
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Diabetes Mellitus Type II Non Insulin Dependent
Interventions: Dietary Supplement: Vitamin E; Dietary Supplement: Vitamin C; Dietary Supplement: Lipid Oxidation
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified August 2011 - Condition: Esophageal Cancer
Interventions: Drug: FOLFOX regimen; Drug: cisplatin; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Procedure: quality-of-life assessment; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); UNICANCER
Recruiting - verified August 2011 - Condition: Sleep Apnea Syndromes
Intervention: Dietary Supplement: Antioxidant cocktail
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified September 2011 - Condition: Chronic Kidney Disease
Interventions: Drug: Niacin; Drug: Active Placebo
Sponsors: Tufts Medical Center; Tufts Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified July 2011 - Conditions: Type 2 Diabetes; Oxidative Stress
Intervention: Biological: ascorbic acid (Vitamin C)
Sponsors: University of Kansas; University of Kansas
Recruiting - verified July 2011 - Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate CancerConditions: Cancer of the Prostate; Prostate Cancer; Prostatic Neoplasms
Interventions: Dietary Supplement: Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E; Drug: Placebo
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Recruiting - verified September 2011 - Condition: Prematurity
Interventions: Drug: Parenteral L-carnitine supplementation; Drug: Parenteral supplementation with sterile water
Sponsors: University Hospital, Tours; University Hospital, Tours
Recruiting - verified February 2011 - Condition: Schizophrenia
Intervention: Drug: Folic Acid
Sponsors: University of Michigan; University of Michigan; National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Condition: Reversal of Coagulopathy
Interventions: Biological: Beriplex® P/N; Biological: Fresh frozen plasma
Sponsors: CSL Behring; CSL Behring
Recruiting - verified May 2012 - Condition: Risperidone-induced Hyperprolactinemia
Intervention: Dietary Supplement: Calcium and Vitamin D
Sponsors: University of Iowa; University of Iowa; National Institutes of Health (NIH); Children's Miracle Network
Recruiting - verified August 2011 - Condition: Metastatic Colorectal Cancer
Interventions: Biological: cetuximab; Drug: 5-FU; Drug: oxaliplatin; Drug: leucovorin
Sponsors: National Surgical Adjuvant Breast and Bowel Project (NSABP); National Surgical Adjuvant Breast and Bowel Project (NSABP); Bristol-Myers Squibb
Recruiting - verified March 2012 - Condition: Hematoma
Interventions: Drug: low molecular weight heparin or unfractionated heparin; Drug: Warfarin or coumadin
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Condition: Ischemic Stroke
Interventions: Drug: Extended-Release Niacin; Drug: Extended-Release Niacin; Drug: Placebo
Sponsors: Henry Ford Health System; Henry Ford Health System
Recruiting - verified July 2011 - Condition: Leukemia
Interventions: Biological: filgrastim; Biological: graft versus host disease prophylaxis/therapy; Drug: cyclophosphamide; Drug: cytarabine; Drug: dasatinib; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: leucovorin calcium; Drug: methotrexate; Drug: methylprednisolone; Drug: prednisone; Drug: vincristine sulfate; Genetic: cytogenetic analysis; Genetic: polymerase chain reaction; Other: flow cytometry; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation; Radiation: total-body irradiation
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Aortic Valve Calcification
Intervention: Dietary Supplement: Vitamin K supplementation
Sponsors: RWTH Aachen University; RWTH Aachen University
Recruiting - verified March 2012 - Condition: Venous Thromboembolism
Intervention:
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Heart and Stroke Foundation of Ontario
Recruiting - verified June 2011 - Condition: Intrauterine Growth Restriction
Interventions: Dietary Supplement: Pomegranate Juice; Dietary Supplement: Placebo
Sponsors: Washington University School of Medicine; Washington University School of Medicine; University of California, Los Angeles
Recruiting - verified August 2011 - Conditions: Lung Cancer; Precancerous Condition
Interventions: Dietary Supplement: inositol; Other: placebo
Sponsors: National Cancer Institute (NCI); Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified August 2009 - Condition: Colorectal Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: Oxaliplatin; Drug: Leucovorin; Drug: 5-FU; Drug: 5-FU; Drug: Leucovorin; Drug: 5-FU; Drug: Irinotecan
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Dietary Supplement: n-3 polyunsaturated fatty acids; Other: Placebo
Sponsors: Columbia University; Columbia University; National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified February 2012 - Condition: Atherosclerosis
Intervention: Dietary Supplement: Crossover of R-alpha lipoic acid and placebo
Sponsors: Oregon State University; Oregon State University; Oregon Health and Science University; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified February 2012 - Condition: Atherosclerosis
Interventions: Dietary Supplement: R-alpha lipoic acid; Dietary Supplement: Placebo
Sponsors: Oregon State University; Oregon State University; Oregon Health and Science University; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified February 2012 - Conditions: Chronic Kidney Disease; Vitamin D Deficiency; Coronary Calcification; Disorders of Calcium and Bone Metabolism
Interventions: Drug: Calcitriol (Rocaltrol®); Drug: Paricalcitol
Sponsors: University of Pennsylvania; University of Pennsylvania; Abbott
Recruiting - verified November 2011 - Conditions: Acute Hepatitis A; Acute Hepatitis B; Acute Hepatitis C; Acute Hepatitis E; Acute EBV Hepatitis; Acute CMV Hepatitis
Interventions: Dietary Supplement: Silymarin; Dietary Supplement: Silymarin; Other: Lactose monohydrate
Sponsors: University of Maryland; University of Maryland; MADAUS GmbH; The Egyptian Company for Blood Transfusion Services (EgyBlood); Tanta Fever Hospital; Banha Fever Hospital; Alexandria University
Recruiting - verified August 2011 - Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin; Drug: 5-Fluorouracil; Drug: Leucovorin; Drug: Bevacizumab; Drug: Irinotecan; Drug: Cetuximab
Sponsors: University Hospital of Crete; University Hospital of Crete
Recruiting - verified July 2011 - Conditions: Vitamin D Deficiency; Insulin Resistance; Type 2 Diabetes Mellitus; Cardiovascular Disease; Hypertension
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Heart, Lung, and Blood Institute (NHLBI); American Diabetes Association
Recruiting - verified November 2011 - Condition: Neonatal Anemia
Interventions: Biological: Transfused Biotin RBCs - Adults Phase I; Biological: Transfused Biotin RBCs - Infants Phase II; Biological: Transfused Biotin RBCs - Infants Phase III
Sponsors: University of Iowa; University of Iowa; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI); Thrasher Research Fund
Recruiting - verified February 2012 - Conditions: Hypercholesterolemia; Vitamin D Deficiency
Interventions: Drug: Vitamin D3 dose titration; Other: Placebo
Sponsors: Jewish Home, San Francisco; Jewish Home, San Francisco; National Institute on Aging (NIA)
Recruiting - verified March 2012 - Condition: Tuberculosis
Interventions: Drug: Rifapentine, Moxifloxacin, Pyrazinamide, Isoniazid; Drug: Isoniazid, Rifampin, Pyrazinamide, Ethambutol
Sponsors: Johns Hopkins University; Johns Hopkins University; Federal University of Rio de Janeiro; Municipal Health Secretary of Rio de Janeiro; Helio Fraga Reference Center, Fiocruz
Recruiting - verified February 2012 - Condition: Statin Induced Myalgia
Interventions: Drug: Coenzyme Q 10; Drug: Placebo control
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Recruiting - verified September 2010 - Conditions: Dyslipidemia; Atherosclerosis
Interventions: Drug: simvastatin; Drug: Nicotinic Acid
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified July 2011 - Condition: Scar
Interventions: Dietary Supplement: Natural Vitamin E Tocotrienol (TCT); Dietary Supplement: Natural Vitamin E Tocotrienol (TCT); Other: Placebo; Other: Placebo Cream
Sponsors: Ohio State University; Chandan Sen
Recruiting - verified March 2012 - Conditions: Hodgkin's Disease; Non-Hodgkin's Lymphoma
Interventions: Drug: Vorinostat (SAHA) and Niacinamide; Drug: Vorinostat, Niacinamide and Etoposide
Sponsors: Columbia University; Columbia University; Merck
Recruiting - verified February 2012 - Conditions: Lung Cancer; Precancerous Condition; Tobacco Use Disorder
Interventions: Dietary Supplement: calcitriol; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified December 2011 - Conditions: End Stage Cardiac Failure; Pulmonary Failure; End Stage Liver Disease; Morbid Obesity; Recalcitrant Epilepsy Requiring Surgery; Healthy Subjects
Interventions: Dietary Supplement: To surgery patients, Tocotrienol or Tocopherol capsules.; Dietary Supplement: Tocotrienol or Tocopherol to healthy subjects.
Sponsors: Ohio State University; Ohio State University
Recruiting - verified August 2011 - Conditions: Paget's Disease of the Bone; Hypocalcemia
Intervention: Drug: Reclast®
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Cancer
Interventions: Dietary Supplement: Multivitamin, Vitamin B12, Vitamin B6.; Dietary Supplement: Vitamin B12, Vitamin B6
Sponsors: New Mexico Cancer Care Alliance; New Mexico Cancer Care Alliance
Recruiting - verified December 2011 - Conditions: Iron Deficiency; Iron Deficiency Anemia
Interventions: Dietary Supplement: Ferrous Sulfate (liquid) + vitamins A and D; Dietary Supplement: vitamins A and D; Dietary Supplement: Ferrous sulfate (liquid)
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Mesothelioma
Interventions: Drug: Standard Chemotherapy (Pemetrexed and Cisplatin); Drug: Standard Chemotherapy (Pemetrexed and Cisplatin) + Bevacizumab
Sponsors: Intergroupe Francophone de Cancerologie Thoracique; Intergroupe Francophone de Cancerologie Thoracique; University Hospital, Caen; Groupe Francais De Pneumo-Cancerologie
Recruiting - verified March 2012 - Conditions: Metastatic Cancer; Prostate Cancer
Interventions: Drug: paricalcitol; Other: immunoenzyme technique; Other: laboratory biomarker analysis; Procedure: dual x-ray absorptometry; Procedure: quality-of-life assessment
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified October 2010 - Condition: Advanced Gastric Cancer
Intervention: Drug: RAD001; Cisplatin; 5-FU; Leucovorin
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital; National Cheng-Kung University Hospital; Taipei Veterans General Hospital,Taiwan
Recruiting - verified December 2010 - Conditions: Iron Deficiency Anemia; Iron Deficiency
Interventions: Dietary Supplement: folic acid + iron prenatally, vits A & D + iron postnatally; Dietary Supplement: folic acid + iron prenatally, vitamins A & D postnatally; Dietary Supplement: folic acid prenatally, vitamins A & D + iron postnatally; Dietary Supplement: folic acid prenatally, vitamins A & D postnatally
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Centers for Disease Control and Prevention
Recruiting - verified January 2012 - Condition: Keratoconus
Interventions: Procedure: Riboflavin/UVA crosslinking; Procedure: Sham treatment
Sponsors: University Hospital Freiburg; University Hospital Freiburg; PESCHKE Meditrade GmbH, Switzerland
Recruiting - verified February 2009 - Conditions: Mortality; Morbidity; Growth; Neonatal Mortality
Interventions: Biological: OPV; Biological: OPV plus BCG; Biological: OPV; Biological: OPV plus BCG
Sponsors: Bandim Health Project; Bandim Health Project; March of Dimes; Danida
Recruiting - verified December 2011 - Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: panitumumab; Drug: everolimus; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: UNC Lineberger Comprehensive Cancer Center; UNC Lineberger Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Huntington's Disease
Interventions: Drug: coenzyme Q10; Other: placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Neurological Disorders and Stroke (NINDS); University of Rochester
Recruiting - verified May 2012 - Condition: Knee Osteoarthritis
Intervention: Dietary Supplement: Vitamin D3 (cholecalciferol)
Sponsors: University of Zurich; University of Zurich; Harvard School of Public Health; Tufts University; Boston University
Recruiting - verified December 2011 - Condition: Autistic Disorder
Interventions: Dietary Supplement: B12; Dietary Supplement: Placebo; Dietary Supplement: folate; Dietary Supplement: B complex; Dietary Supplement: vitamin C; Dietary Supplement: cod liver oil; Dietary Supplement: Mineral complex; Dietary Supplement: carnitine
Sponsors: Arkansas Children's Hospital Research Institute; Arkansas Children's Hospital Research Institute
Recruiting - verified January 2012 - Condition: Parkinson's Disease
Intervention: Drug: VITAMIN D
Sponsors: Emory University; Emory University
Recruiting - verified May 2012 - Condition: Osteopenia
Intervention: Other: exercise intervention
Sponsors: University of Missouri-Columbia; University of Missouri-Columbia; National Institutes of Health (NIH)
Recruiting - verified September 2011 - Condition: Leukemia
Interventions: Drug: asparaginase; Drug: cyclophosphamide; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: etoposide; Drug: lestaurtinib; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: methylprednisolone; Drug: pegaspargase; Drug: prednisone; Drug: therapeutic hydrocortisone; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Osteoarthritis of Hip; Traumatic Arthritis of Hip
Intervention: Procedure: Hip replacement
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Biomet, Inc.
Recruiting - verified June 2011 - Condition: Prostate Cancer
Interventions: Dietary Supplement: calcitriol; Drug: ketoconazole; Drug: therapeutic hydrocortisone
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; Department of Defense
Recruiting - verified January 2012 - Conditions: Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Endothelial Cells; Vitamin D
Intervention: Drug: doxercalciferol
Sponsors: Duke University; Duke University; Genzyme
Recruiting - verified June 2011 - Conditions: Gastroesophageal Junction Adenocarcinoma; Gastric Cancer
Interventions: Drug: Docetaxel, Leucovorin, Fluorouracil, Cisplatin; Drug: Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Sanofi-Aventis; Roche/Genetech; City of Hope National Medical Center; Piedmont Hospital Research Institute (PHRI); Medical College of Wisconsin; Queens Health Network; Weill Medical College of Cornell University; Memorial Cancer Institute, Florida; University of Pittsburgh; Long Island Jewish Medical Center; Nebraska Cancer Specialists Methodist Estabrook Cancer Center
Recruiting - verified January 2012 - Condition: Prostate Cancer
Interventions: Dietary Supplement: cholecalciferol; Dietary Supplement: genistein; Dietary Supplement: soy isoflavones; Genetic: polymerase chain reaction; Genetic: protein expression analysis; Other: immunologic technique; Other: laboratory biomarker analysis
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Colorectal Cancer
Interventions: Drug: 5-FU; Drug: Cetuximab; Drug: Dasatinib; Drug: Leucovorin; Drug: Oxaliplatin
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Bristol-Myers Squibb
Recruiting - verified December 2011 - Conditions: Colorectal Cancer; Metastatic Cancer
Interventions: Biological: cetuximab; Drug: capecitabine; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Other: study of socioeconomic and demographic variables; Procedure: adjuvant therapy; Procedure: neoadjuvant therapy; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Southampton University Hospitals NHS Trust
Recruiting - verified April 2008 - Conditions: Neoplasm Metastasis; Colorectal Cancer
Interventions: Drug: 5-FU; Drug: folinic acid; Drug: irinotecan; Drug: cetuximab; Drug: bevacizumab
Sponsors: Ludwig-Maximilians - University of Munich; Ludwig-Maximilians - University of Munich; Merck
Recruiting - verified June 2009 - Condition: Mitochondrial Diseases
Interventions: Drug: CoenzymeQ10; Drug: Coenzyme Q10; Drug: Placebo
Sponsors: University of Florida; University of Florida; FDA Office of Orphan Products Development
Recruiting - verified March 2012 - Conditions: Leukemia; Lymphoma
Interventions: Drug: cyclophosphamide; Drug: cytarabine; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: nelarabine; Drug: pegaspargase; Drug: prednisone; Drug: thioguanine; Drug: vincristine sulfate; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Leukemia
Interventions: Biological: filgrastim; Drug: asparaginase; Drug: cyclophosphamide; Drug: cytarabine; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: etoposide phosphate; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: prednisone; Drug: therapeutic hydrocortisone; Drug: vincristine sulfate; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Progressive Supranuclear Palsy; Atypical Parkinsonism
Intervention: Drug: Coenzyme Q10
Sponsors: Lahey Clinic; Lahey Clinic
Recruiting - verified February 2012 - Condition: Colorectal Cancer
Interventions: Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Procedure: conventional surgery; Radiation: radiation therapy
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: leucovorin calcium; Drug: methotrexate; Drug: thiotepa; Drug: vincristine sulfate
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Conditions: Brain and Central Nervous System Tumors; Lymphoma
Interventions: Drug: Rituxan; Drug: Carboplatin; Drug: Methotrexate; Drug: Sodium thiosulfate; Drug: Neupogen; Drug: Neulasta; Drug: Leucovorin
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Childhood Langerhans Cell Histiocytosis
Interventions: Drug: leucovorin calcium; Drug: methotrexate; Drug: prednisolone; Drug: vinblastine sulfate
Sponsors: National Cancer Institute (NCI); Histiocyte Society
Recruiting - verified May 2007 - Conditions: AIDS-Related Primary Central Nervous System Lymphoma; HIV
Interventions: Drug: Methotrexate; Biological: rituximab; Procedure: antiviral therapy; Drug: leucovorin calcium
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Drug: dl-alpha-tocopherol; Drug: Memantine; Drug: dl-alpha-tocopherol; Drug: Memantine; Drug: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Forest Laboratories; DSM Nutritional Products, Inc.
Recruiting - verified April 2012 - Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: gemcitabine hydrochloride; Drug: paricalcitol
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; Abbott
Recruiting - verified January 2012 - Condition: Diabetic Nephropathies
Intervention: Drug: Folic Acid
Sponsors: University of Erlangen-Nürnberg Medical School; University of Erlangen-Nürnberg Medical School
Recruiting - verified October 2011 - Conditions: Amino Acid Metabolism; Inborn Errors
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified July 2011 - Condition: Diabetes Mellitus
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2011 - Condition: Schizophrenia
Intervention: Drug: Tolcapone
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Conditions: Hypocalcemia; Osteomalacia; Pseudohypoparathyroidism; Pseudo-Pseudohypoparathyroidism; Rickets
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2011 - Condition: Healthy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Condition: Hypoparathyroidism
Intervention: Drug: PTH 1-34
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: Hyperparathyroidism; Hypocalcemia; Hypoparathyroidism; Parathyroid Neoplasm
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified June 2011
 |
Join Clinical Trials that Study Vitamins |
